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Abstract 
The genetic code underlying protein synthesis is a canonical example of a degenerate 
biological system. Degeneracies in physical and biological systems can be lifted by external 
perturbations thus allowing degenerate systems to exhibit a wide range of behaviors. Here we 
show that the degeneracy of the genetic code is lifted by environmental perturbations to regulate 
protein levels in living cells. By measuring protein synthesis rates from a synthetic reporter 
library in Escherichia coli, we find that environmental perturbations, such as reduction of 
cognate amino acid supply, lift the degeneracy of the genetic code by splitting codon families 
into a hierarchy of robust and sensitive synonymous codons. Rates of protein synthesis 
associated with robust codons are up to 100-fold higher than those associated with sensitive 
codons under these conditions. We find that the observed hierarchy between synonymous codons 
is not determined by usual rules associated with tRNA abundance and codon usage.  Rather, 
competition among tRNA isoacceptors for aminoacylation underlies the robustness of protein 
synthesis. Remarkably, the hierarchy established using the synthetic library also explains the 
measured robustness of synthesis for endogenous proteins in E. coli. We further found that the 
same hierarchy is reflected in the fitness cost of synonymous mutations in amino acid 
biosynthesis genes and in the transcriptional control of sigma factor genes. Our study reveals that 
the degeneracy of the genetic code can be lifted by environmental perturbations, and it suggests 
that organisms can exploit degeneracy lifting as a general strategy to adapt protein synthesis to 
their environment.  
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Introduction 
Degeneracy, the occurrence of distinct states that share a common function, is a 
ubiquitous property of physical and biological systems (1–3). Examples of degenerate systems 
include atomic spectra (4), condensed matter (5), the nervous system (2) and the genetic code (6, 
7). Degeneracy in physical systems is often associated with underlying symmetries (1), and in 
biological systems with error-minimization, evolvability, and robustness against perturbations 
(8). Degenerate states that are indistinguishable under normal conditions can exhibit distinct 
properties under the action of external perturbations (1). This effect, called degeneracy lifting,   
allows degenerate systems to exhibit a wide range of behaviors depending on the environmental 
context (2). The genetic code governing protein synthesis is a highly degenerate system since 18 
of the 20 amino acids have multiple synonymous codons and 10 of the 20 amino acids are 
aminoacylated (charged) onto multiple tRNA isoacceptors. Protein synthesis rates in living cells 
respond to diverse environmental perturbations, which raises the question of whether any of 
these perturbations modulates protein levels by lifting the degeneracy of the genetic code. 
Previous experiments found that both the concentration of charged tRNAs as well as the 
occupancy of ribosomes on synonymous codons undergo significant changes upon nutrient 
limitation (9–11). Yet whether such environmental perturbations lift the degeneracy of the 
genetic code by modulating the expression level of proteins is unknown. Here, we propose to use 
amino acid limitation in the bacterium Escherichia coli as a model system to investigate whether 
the degeneracy of the genetic code can be lifted by environmental perturbations, and how 
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degeneracy lifting could provide a general strategy to adapt protein synthesis to environmental 
changes. 
Results 
Degeneracy lifting upon amino acid limitation 
We considered synonymous codons for seven amino acids: Leu, Arg, Ser, Pro, Ile, Gln, 
and Phe. This set of seven amino acids is representative of the degeneracy of the genetic code, in 
that it includes six-, four-, three- and two-fold degenerate codon families. We constructed a 
library of 29 yellow fluorescent protein (yfp) gene variants, each of which had between six and 
eight synonymous mutations for one of the seven amino acids (Fig. 1A). In this library, we 
designed each yfp variant to characterize the effect of one specific codon on protein synthesis. 
We expressed the yfp variants constitutively at low gene dosage (2 copies / chromosome, Fig. 
1B) in E. coli strains that were auxotrophic for one or more amino acids. We monitored growth 
and YFP synthesis in these strains during amino acid-rich growth as well as during limitation for 
each of the seven amino acids (Methods). 
During amino acid-rich growth, our measurements revealed that protein synthesis rates 
were highly similar across yfp variants, with less than 1.4-fold variation within all codon families 
(Fig. 1D, grey bars). Thus, under rich conditions, the degeneracy of the genetic code remains 
intact with respect to protein synthesis. Strikingly, under amino acid-limited growth, codon 
families split into a hierarchy of YFP synthesis rates (Fig. 1C, 1D). We found that some 
synonymous codons, such as CTA for leucine, were highly sensitive to environmental 
perturbation, causing YFP synthesis rates to be near zero in response to the limitation of these 
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codons’ cognate amino acids. Conversely, other synonymous codons, such as CTG for leucine, 
were more robust to the same perturbation with synthesis rates of YFP up to 100-fold higher than 
the sensitive ones
*
. In addition to fluorescence, this difference in robustness was reflected in 
protein levels measured with Western blotting (Fig. S1). Notably, even a single substitution to a 
perturbation-sensitive codon in the yfp coding sequence resulted in more than a 2-fold difference 
in YFP synthesis rate during limitation for the cognate amino acid, without any effect on 
synthesis rate during amino acid-rich growth (Fig. S2). Only those codons that were cognate to 
the limiting amino acid caused splitting of YFP synthesis rates (Fig. S3). Interestingly, the 
splitting was more acute for codon families with six-fold degeneracy (Leu, Arg, Ser), while 
splitting was weaker for codon families with four-, three- and two-fold degeneracies (Fig. 1D, 
first row vs. second row). These results support the idea that greater degeneracy typically allows 
systems to exhibit wider range of responses to environmental perturbations (2). In subsequent 
experiments, we focused on the two codon families, leucine and arginine that displayed the 
largest range of splitting. These two families constitute 16% of codons across the genome of E. 
coli. 
Intracellular determinants of the hierarchy among synonymous codons 
We sought to identify the intracellular parameters that determine the observed hierarchy 
of degeneracy splitting during amino acid limitation. To this end, we quantified the robustness of 
synthesis rate to amino acid limitation as the ratio of YFP synthesis rates between amino acid-
limited and amino acid-rich growth phases. Protein synthesis rate is known to be correlated with 
                                                 
*
 We define codons as robust when the synthesis rate from the corresponding yfp variant during cognate amino acid 
limitation is higher than the average synthesis rate within that codon family. Similarly, we define codons as sensitive 
when the synthesis rate from the corresponding yfp variant during cognate amino acid limitation is lower than the 
average synthesis rate within that codon family. 
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codon usage and tRNA abundance during artificial over-expression of proteins (12, 13). 
However, we found that robustness of YFP synthesis to amino acid limitation was not correlated 
with either codon usage or tRNA abundance (r
2
 = 0.08 and 0.00, squared Spearman rank-
correlation, Fig. S4). We then considered determinants of protein synthesis that might be 
important specifically during amino acid limitation. tRNA isoacceptors are uniformly charged 
(aminoacylated) at about 80% under amino acid-rich conditions (14, 15). However during 
perturbations such as amino acid limitation, some tRNA isoacceptors cognate to the amino acid 
are almost fully charged while other isoacceptors in the same family have charged fractions that 
are close to zero (10, 16). A theoretical model proposed that such selective charging arises from 
differences in the relative supply and demand for charged tRNA isoacceptors (9). While it is 
unclear how this mechanism could solely control protein levels, charged tRNA play an essential 
role as substrates for the elongation of ribosomes across individual codons (17). Consequently, 
we hypothesized that selective charging of tRNA isoacceptors also underlies the observed 
splitting in synthesis rates among yfp variants. Consistent with this hypothesis, charged fractions 
of leucine and arginine tRNA isoacceptors during limitation of cognate amino acid starvation 
measured in a previous work (10) were correlated with the robustness of synthesis rates from yfp 
variants after accounting for codon-tRNA assignments (r
2
 = 0.78, Fig. S5). 
We experimentally tested whether varying the concentration of charged tRNA could 
change the hierarchy of protein synthesis rates initially revealed by amino acid limitation. To this 
end, we co-expressed each one of the leucine or arginine tRNA isoacceptors together with each 
of the six leucine or arginine variants of yfp, respectively (Fig. 2). Previous work (16) showed 
that overexpression of a single tRNA isoacceptor cognate to a limiting amino acid enables it to 
compete better in the common charging reaction against other isoacceptors. As a result, charged 
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tRNA concentration of the overexpressed isoacceptor increases, while charged tRNA 
concentrations of the remaining isoacceptors for that amino acid decrease or remain unchanged 
(16). We found that yfp variants constructed with perturbation-sensitive codons exhibited higher 
synthesis rates upon co-expression of tRNA isoacceptors cognate to those perturbation-sensitive 
codons (Fig. 2, A-B , bottom three rows, solid black-outlined squares). Conversely, yfp variants 
with perturbation-robust codons exhibited lower protein synthesis rates upon co-expression of 
non-cognate tRNA isoacceptors (Fig. 2, A-B, top three rows, non-outlined squares). These two 
patterns of changes in YFP synthesis rate mirror previously measured changes in charged tRNA 
concentration upon tRNA co-expression (16), thereby suggesting that the observed hierarchy in 
synthesis rates of yfp variants are tightly coupled with the concentrations of cognate charged 
tRNA isoacceptors during amino acid limitation. By contrast, tRNA co-expression did not affect 
synthesis rates from yfp variants in the absence of perturbation, i.e., during amino acid-rich 
growth (Fig. 2C). We observed several codon-tRNA pairs with mismatches at the wobble 
position but that do not satisfy known wobble-pairing rules (Table S9), and that showed an 
increase in YFP synthesis rate upon co-expression of the tRNA isoacceptor during amino acid 
limitation (Fig. 2, A-B , dashed black-outlined squares). 
A codon robustness index for endogenous proteins 
We investigated whether the hierarchy of synthesis rates measured for the synthetic yfp 
variants also governs the synthesis of endogenous proteins of E. coli. We first devised a general 
parameter, hereafter called the codon robustness index (CRI), to characterize the robustness of 
any protein’s synthesis rate to an environmental perturbation associated with limitation of a 
specific amino acid (Fig. 3A). We defined CRI as a product of codon-specific weights wcodon, and 
we inferred these weights from the synthesis robustness of yfp variants to limitation for their 
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cognate amino acid (Fig. 3B). Our formulation of CRI is based on the simplifying assumption 
that each codon decreases protein synthesis rate by a factor wcodon that is independent of the 
codon’s intragenic location, the presence of other codons in the coding sequence, or the specific 
cellular role of the encoded protein. By definition, wcodon is unity for codons that are not cognate 
to the limiting amino acid, and perturbation-robust codons have a higher wcodon value than 
perturbation-sensitive codons for the limiting amino acid. 
To test the predictive power of CRI, we selected 92 E. coli open reading frames (ORFs) 
that span a broad range of leucine CRI values and functional categories (Fig. S7, Table S1). We 
expressed the corresponding proteins constitutively as N-terminus fusions with YFP
†
 in an E. 
coli strain auxotrophic for leucine (Fig. 3C, Inset,). Upon leucine limitation, we found a strong 
correlation between the robustness of protein synthesis rates from the 92 ORF-yfp fusions and 
their leucine CRI values (Fig. 3C, r
2
=0.61, P=10
-23
, squared Spearman rank-correlation). 
Similarly, arginine CRI was also strongly correlated with robustness of a library of 56 ORF-yfp 
fusions during arginine limitation (r
2
=0.59, P=10
-12
, Fig. S8, Table S2). By contrast, standard 
measures of translation efficiency under amino acid-rich conditions such as codon adaptation 
index (18), tRNA adaptation index (19) or folding energy of the mRNA around the start codon 
(20) displayed only a weak correlation with protein synthesis rate from the ORF-yfp fusions 
during amino acid-rich growth (r
2
 = 0.10, 0.08, and 0.02 resp., Fig. S9). We further found that 
changes in Leu CRI calculated from the yfp data could predict both the effect of tRNA co-
expression and that of synonymous mutations on protein synthesis from E. coli ORFs during 
                                                 
†
 The YFP fusion partner in the 92 ORF-yfp fusions used for testing Leu CRI was encoded by the CTG variant of 
yfp that has the highest, most robust synthesis rate during leucine limitation. Similarly, the YFP fusion partner in the 
56 ORF-yfp fusions used for testing Arg CRI was encoded by the AGA variant of yfp that has the highest, most 
robust synthesis rate during arginine limitation. 
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leucine limitation (Fig. 3D, Fig. S10). Importantly, similar to our results using yfp reporters, 
neither tRNA co-expression nor synonymous mutations for E.coli ORF-yfp fusions had a 
significant effect on the synthesis rates from these ORFs during leucine-rich growth in absence 
of environmental perturbations (Fig. S11). Thus the degeneracy of the genetic code underlies the 
levels of endogenous protein production only during response to environmental perturbations. 
Consequences of degeneracy lifting for fitness and gene regulation 
Degeneracy splitting in physical systems can be exploited to encode information related 
to the environmental context (21, 22). We asked whether bacteria might similarly exploit the 
degeneracy splitting of genetic code during response to amino acid limitation. Hence we tested 
whether the expression of amino acid biosynthesis genes that enable bacteria to adapt to amino 
acid limitation is affected by the hierarchy between robust and sensitive codons. We found that 
mutating codons that are perturbation-robust to those that are perturbation-sensitive in the 
leucine-biosynthesis genes leuA, leuC and leuD, and the arginine biosynthetic gene carA 
decreased their protein synthesis rate during cognate amino acid limitation, but not during amino 
acid-rich growth (Fig. S12). Interestingly, in the case of leuA and carA, the same synonymous 
mutations also resulted in a fitness cost for prototrophic strains upon downshift from amino acid-
rich to amino acid-poor conditions (Fig. 4A). Thus synonymous mutations can have a significant 
fitness cost during an environmental perturbation, which is distinct from that measured under 
nutrient-rich conditions in the absence of any perturbation (20, 23). However swapping codons 
that are perturbation-robust to those that are perturbation-sensitive in other biosynthesis genes 
(see argA and leuC in Fig. 4A) did not significantly affect fitness, suggesting that the hierarchy 
of robust and sensitive codons might be selectively utilized by bacteria to regulate genes within a 
single metabolic pathway. 
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Perturbations associated with amino acid limitation in E. coli can result in two distinct 
outcomes, depending on the environmental conditions: On one hand, when substrates used in 
amino acid biosynthesis are still abundant in the environment, the cell up-regulates 
corresponding biosynthesis genes to mitigate the limitation of amino acids and resume growth. 
On the other hand, in the absence of substrates for amino acid biosynthesis, E. coli can survive a 
prolonged period in amino acid-poor environments through a cellular response mediated by 
sigma factors (24, 25). We found that genes encoding several stress-response sigma factors 
(rpoS, rpoE and rpoH) are enriched in TTA and TTG, the leucine codons that ensure robust 
protein synthesis during leucine limitation (Fig. 4B, top panel). By contrast, genes for the 
housekeeping sigma factor (rpoD) and a few minor sigma factors (fecI, fliA) are enriched for 
CTC and CTT, which are sensitive to leucine limitation. This contrasting pattern is observed for 
leucine (but not for arginine), and is further mirrored by the change in transcript abundance for 
sigma factor genes in response to leucine limitation (Fig. 4B, bottom panel). Hence degeneracy 
splitting in the genetic code might be exploited in concert with transcriptional control to regulate 
protein levels. 
Discussion 
In summary, we have found that the degeneracy of the genetic code does not have a role 
in regulating protein synthesis during amino acid-rich growth. By contrast, the splitting of this 
degeneracy upon reduction in amino acid supply has a potent effect on protein synthesis that 
results in up to 100-fold differences in protein synthesis rates between synonymous gene 
variants. Such a large role for synonymous codons in protein synthesis is surprising given that 
other post-transcriptional mechanisms such as protein degradation are known to play a 
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significant role upon amino acid limitation (26). We identified competition between tRNA 
isoacceptors for aminoacylation as a key determinant of the hierarchy of protein synthesis rates 
during amino acid limitation. Low concentration of a charged tRNA isoacceptor can cause 
ribosomes to selectively pause at its cognate codon
‡
 and trigger ribosome jamming (27), 
translation-recoding (28), mRNA cleavage (29–31) or feedback-transcriptional control (32, 33). 
It will be interesting to find the relative contribution of these different molecular processes to the 
degeneracy lifting uncovered here
§
. Here, we have investigated the effect of a specific 
environmental perturbation associated with amino acid limitation in the bacterium E. coli. 
However, this type of perturbation plays a crucial role in the lifecycle of other bacteria such as 
Myxococcus xanthus and Bacillus subtilis that undergo differentiation cued by amino acid 
limitation (34, 35). Protein synthesis during such differentiation events might also be regulated 
by degeneracy lifting of the genetic code. Moreover, degeneracy lifting could be important 
during protein synthesis in eukaryotes, where clinically-important conditions such as neoplastic 
transformation and drug treatment are often accompanied by a reduction in amino acid supply 
(36, 37). Therefore lifting the degeneracy of the genetic code might emerge as a general strategy 
for biological systems to expand their repertoire of responses to environmental perturbations. 
                                                 
‡
 A recent genome-wide study found increased ribosome pausing at serine codons during serine-limited growth of E. 
coli. Interestingly, ribosomes paused significantly only at four out of the six serine codons, and these four codons are 
precisely the same ones that caused YFP synthesis rate to be sensitive to serine limitation in our experiments (Fig. 
S13). 
§
 We measured the change in mRNA levels of different yfp variants in response to amino acid limitation. Changes in 
mRNA levels were correlated with corresponding changes in YFP synthesis rates upon amino acid limitation (Fig. 
S14). However, changes in mRNA levels were smaller than expected, suggesting that changes in mRNA abundance 
induced by ribosome pausing might not be solely responsible for the observed changes in protein synthesis rate. 
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Materials and Methods 
Summary of key methods are given below. Detailed methods for all experiments and analyses 
are included in Appendix. 
Bacterial strains 
All strains used in this study were obtained from the E.coli Genetic Stock Center (CGSC), Yale 
University. Different auxotrophic strains were used depending on the amino acid that was 
limiting in the growth medium (Table S5). Strains were stored as 20% glycerol stocks at -80C 
either in 1ml cryo-vials or in 96-well plates (3799, Costar). For experiments involving over 25 
strains, a temporary 20% glycerol stock was stored at -20C in 96-well PCR plates. 
Plasmids 
The pZ series of plasmids (39) were used for expression of all genes constructed for this study. 
General features of the plasmid backbones are described here. Details on individual gene 
constructs that were inserted into these plasmid backbones, including DNA sequences and 
plasmid maps, are in Appendix. A low-copy plasmid, pZS*11 [SC101* ori (3-4 copies/cell), 
Amp
R
 (bla gene) and a constitutive PLtetO-1 promoter] was used for expression of all fluorescent 
reporter genes and their fusions. The synthetic ribosome binding site (RBS) in the original 
pZS*11 backbone was replaced by a modified T7-based RBS that resulted in efficient expression 
of most coding sequences. A medium-copy plasmid, pZA32 [p15A ori (10-12 copies/cell), Chl
R
 
(cat gene) and PLlacO-1 promoter] was used for expression of all tRNA genes. Strains with pZA32 
plasmids were grown with 1mM IPTG to ensure constitutive expression of all tRNA genes. 
Standard plasmids pUC18 and pUC19 were used as intermediate cloning vectors for site-directed 
mutagenesis. 
Gene synthesis and cloning 
A single yfp sequence was built de novo (synthesis by Genscript, USA). All subsequent yfp 
variants were constructed using a site-directed mutagenesis kit (Stratagene). tRNA genes and E. 
coli ORFs were amplified from the chromosome of a wild-type E. coli strain (MG1655) by PCR 
(Details on cloning and genes sequences in Appendix). 
Amino acid limitation experiments 
Overnight cultures were inoculated from glycerol stocks or fresh colonies and grown in a MOPS-
based rich-defined medium with 800µM of 19 amino acids and 10mM serine at 30C with 
shaking. For experiments involving amino acid limitation, overnight cultures were diluted 
1:1000 into a similar rich-defined medium as the overnight cultures. However the amino acid, 
whose limitation was to be induced, was added at a reduced concentration and supplemented 
with its methyl-ester analog (see Table S6 for exact concentrations). Amino acid methyl-esters 
are inefficiently metabolized analogs of the corresponding amino acids and have been previously 
used for steady growth of E. coli under amino acid limiting conditions (40, 41) (see Figs. S15 
and S16 for the effect of methyl-ester on growth and measured robustness during amino acid 
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limited growth). Slight variations in the initial concentration of either the limiting amino acid or 
its methyl-ester only results in shifting of the transition to a higher or lower cell density without 
appreciable changes in growth rate (see Notes S1 and S2). Growth and fluorescence were 
quantified using a standard 96-well plate reader integrated with a robotic system. Further details 
on growth protocols are given in Appendix. 
Analysis of cell density and fluorescence time series 
Matlab R2009 (Mathworks) was used for all analyses unless otherwise mentioned. All 
correlations and P-values reported in this work were calculated using the Matlab command ‘corr’ 
with the ‘Type’ option set to either ‘Spearman’ or ‘Pearson’ as appropriate. Growth and 
fluorescence time series were fit with exponential and linear curves in the amino acid rich and 
amino acid limited growth regimes, respectively, and the onset time of amino acid limited 
growth was automatically inferred from their intersection. Protein synthesis rate, S was 
calculated as: 
  
 
First, the above formula was evaluated at the onset time of amino acid limited growth using the 
exponential fits for absorbance and fluorescence data in the amino acid rich growth regime. 
Next, the same formula was evaluated at the onset time using the linear fits for absorbance and 
fluorescence data in the amino acid limited growth regime. These two values correspond to the 
protein synthesis rates reported for the amino acid rich and amino acid limited growth regimes 
(such as the data in Fig. 1D). Further details of this analysis are given in Appendix. 
Calculation of CRI 
CRI for a protein coding sequence corresponding to a limiting amino acid was calculated by 
multiplying the wi values for codons cognate to the limiting amino acid in that sequence. wi 
values shown in Fig. 3B were calculated using the robustness of protein synthesis of the 
corresponding yfp variants during cognate amino acid limitation (Fig. 1D). Based on our non-
cognate limitation experiment (Fig. S2), the wi values for all codons other than those cognate to 
the limiting amino acid are set to be equal to 1. 
For illustration, we demonstrate the calculation of wi for the 6 Leu codons below. The exact 
same procedure was followed for other synonymous codon families. Taking  for 
each codon, and  for each yfp 
variant,  
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The multiplicative factors on the LHS in front of Wi correspond to the number of different Leu 
codons in the corresponding Leu variant of yfp (see Fig. 1A). The RHS is the measured (log2) 
robustness of protein synthesis from the corresponding yfp variant during Leu limitation (see Fig. 
1D). These equations were solved simultaneously to determine the wi value for each Leu codon. 
Revised wi values based on yfp measurements in the presence of 
GAG
Leu2 tRNA (Fig. 2) were 
used for calculation of Leu CRI in the case of 
GAG
Leu2 tRNA co-expression with E. coli ORFs 
(Fig. 3D). 
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Figure Legends 
Fig. 1: Degeneracy lifting associated with amino acid limitation. 
(A) A library of 29 variants of the yellow fluorescent protein gene (yfp) was synthesized. In this 
library, each variant (represented as a horizontal line) was designed to measure the effect of one 
specific codon on protein synthesis rate. The identity of this codon and that of its cognate amino 
acid is indicated to the left of each yfp variant, and the locations of this codon along yfp are 
represented as thick vertical bars. Other codons for the same amino acid that were identical 
across all yfp variants in each codon family are represented as thin vertical bars. 
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(B) Each yfp variant was constitutively expressed from a low-copy vector (SC101* ori, 2 copies / 
chromosome) in E. coli strains that were auxotrophic for one or more of seven amino acids. 
(C) To induce amino acid limited growth, we adjusted the initial concentration of an amino acid 
in the growth medium to a level below that is required for reaching saturating cell density. A 
methyl-ester analog of the amino acid supported steady growth in the amino-acid limited phase. 
Growth and fluorescence curves for two yfp variants, CTA, red, and CTG, black, are shown as 
illustrative examples of degeneracy splitting upon limitation for the cognate amino acid, leucine. 
 (D) YFP synthesis rates during limitation for cognate amino acid  – blue; YFP synthesis rates 
during amino acid-rich growth – grey. YFP synthesis rate was defined as the rate of fluorescence 
change divided by the cell density. Synthesis rates were normalized by the maximum value 
within each synonymous codon family, and separately in the amino acid-rich and amino acid-
limited growth phases. Normalization factors (amino acid – rich, limited): Leu – 94, 81; Arg – 
89, 113; Ser – 217, 343; Pro – 306, 49; Ile – 295, 45; Gln – 185, 83; Phe – 311, 20; (arbitrary 
units). Error bars show standard error over three replicate cultures. 
Fig. 2: Altering the hierarchy of degeneracy splitting among synonymous 
codons. 
The five leucine (arginine) tRNA isoacceptors were co-expressed together with each of the six 
leucine (arginine) yfp variants resulting in thirty tRNA-yfp combinations for leucine (arginine). 
(A, B) Each square in the left (right) table corresponds to the difference in YFP synthesis rates of 
each yfp variant between the tRNA co-expressed strain and the parent strain without extra tRNA 
during leucine (arginine) limitation. YFP synthesis rates were defined in the same manner and 
normalized by the same factor as in Fig. 1D. YFP synthesis rate of the parent strain without extra 
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tRNA during amino acid limitation is shown on the left of each table (same data as in Fig. 1D). 
tRNA isoacceptor names are preceded by their unmodified anticodon sequences. Solid black-
outlined squares correspond to codon–tRNA pairs that satisfy wobble-pairing rules after 
accounting for known post-transcriptional tRNA modifications (Table S9). Dashed black-
outlined squares correspond to codon–tRNA pairs that do not satisfy known wobble-pairing rules 
but that show a significant increase in YFP synthesis rate upon co-expression of the tRNA 
isoacceptor.  
UCG
Arg2m is a non-native arginine tRNA that was created by mutating the anticodon 
sequence of the 
ACG
Arg2 gene. Standard error was less than 0.05 for all squares. 
(C) Histogram of differences in YFP synthesis rate of yfp variants upon tRNA co-expression. 
Amino acid limited growth: 42% median difference;  Amino acid-rich growth: 9% median 
difference (n=60, aggregated for leucine and arginine). Change in YFP synthesis rate between 
each tRNA co-expressed strain and its parent strain expressing no extra tRNA was calculated as 
a percentage of the largest value between the two YFP synthesis rates. 
Fig. 3: Degeneracy lifting for endogenous proteins. 
(A) The effect of each codon on the synthesis rate, S, of a protein during amino acid limitation 
was modeled by a codon-specific weight, wcodon. The codon robustness index (CRI) for any 
protein coding sequence was defined as the product of wcodon values for all codons in that 
sequence that are cognate to the limiting amino acid. 
(B) wcodon values for leucine and arginine codons during limitation for their cognate amino acids 
were estimated from protein synthesis rates of the corresponding yfp variants (Methods). wcodon 
values for all codons not cognate to the limiting acid were set to 1. 
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(C) Ninety-two open reading frames (ORFs) from the E. coli genome were cloned as N-terminal 
fusions to YFP downstream a constitutive promoter into a low-copy vector (Inset, Methods). 
Robustness to leucine limitation is quantified as the ratio of protein synthesis rates between 
leucine-limited and leucine-rich growth phases. This measured robustness was correlated with 
estimated Leu CRI values for the 92 ORF-yfp fusions (r
2
=0.61, squared Spearman rank-
correlation, P = 10
-20
). 11 ORFs had measured robustness below the lower limit of the vertical 
axis (Table S1), but were included in the calculation of r
2
. Protein synthesis rates were 
normalized by the synthesis rate for the CTG variant of yfp. Error bars show standard error over 
three replicate cultures. 
(D) Two sets of ORF-yfp fusions (21 total ORFs) were co-expressed with 
GAG
Leu2 tRNA. Based 
on the yfp data (Fig. 2A), we estimated a higher CRI for the first set (11 ORFs) and a lower CRI 
for the second set (10 ORFs) upon 
GAG
Leu2 co-expression (Left panel, Methods). Hence we 
predicted that the first set should show an increase in robustness of protein synthesis during 
leucine limitation while the second set should show a decrease. These predictions agreed with 
measured changes for 20 of the 21 ORFs (Right panel, r
2
 = 0.57, P = 10
-4
). Error bars show 
standard error over three replicate cultures. Several error bars are smaller than data markers. 
Fig. 4. Fitness cost and transcriptional control reflect degeneracy lifting. 
(A) Four different prototrophic E. coli strains were created. Each of these strains had one of the 
four amino acid biosynthesis genes argA (Arg), carA (Arg), leuA (Leu) and leuC (Leu) replaced 
at the native locus by a corresponding synonymous mutant ORF. These mutants were designed 
such that three to five perturbation-robust codons in wild-type ORF were replaced by 
perturbation-sensitive codons in the mutant ORF (see Fig. S12, B). The strains were grown in 
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medium supplemented with all 20 amino acids at 800µM, and then diluted into a medium lacking 
either leucine (left panel) or arginine (right panel). Growth lag was calculated as the time taken 
by each strain to reach OD600 of 0.3 relative to a reference culture of the same strain grown in 
800µM of all 20 amino acids. Difference in growth lag between the leuA mutant and the two 
controls during leucine downshift (left panel) was 9.2 ± 2.8 min, P = 10
-3
. Difference in growth 
lag between the carA mutant and the two controls during arginine downshift (right panel) was 
7.8 ± 1.2 min, P = 10
-6
. Standard errors were calculated over six biological replicates for each 
mutant. P-values were calculated using two-tailed t-test between the leuA or carA mutant and the 
corresponding controls. 
(B) (Top panel) Genes encoding sigma factors and leucine biosynthesis genes in E. coli are 
biased in their Leu CRI values, as quantified using a z-score that measures the normalized 
deviation from the expected CRI value based on genome-wide codon frequencies (Appendix). 
The most frequent leucine codon CTG was excluded in this analysis since its frequency varies 
significantly with expression level under nutrient-rich conditions (38). (Bottom panel) Fold-
change in mRNA abundance in response to leucine limitation for sigma factor genes and leucine 
biosynthesis operons was measured using RT-qPCR. Fold-change of the gapA gene was used for 
internal normalization. Error bars show standard error over triplicate qPCR measurements.
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Fig. S1. Protein levels quantified through Western blotting reflect the difference in 
YFP synthesis rates during amino acid limitation. 
We created modified versions of 29 yfp variants (Fig. 1A) that had a 3X-FLAG tag at the 5’ end. 
These yfp variants were transformed into the respective E. coli auxotrophs in which YFP 
synthesis was repressed by the TetR protein (Methods). Cells were harvested at an OD600 of 0.4 
and re-suspended in medium with or without the corresponding amino acid. Expression of YFP 
was induced using 200ng/ml anhydrotetracyline, and cells were harvested after 60 min. For each 
set of yfp variants under a specific growth condition, the same amount of total protein (as 
measured by OD600 before cell lysis) was used for Western blotting.  
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Fig. S2. Effect of a single synonymous mutation on YFP synthesis rate. 
We synthesized 22 variants of the yfp gene each of which had a single CTA codon at one of the 
22 leucine codon locations along yfp. The remaining leucine codons in each variant were the 
perturbation-robust CTG codon. The ‘control’ yfp variant did not have any CTA codon. Vertical 
axis refers to the YFP synthesis rate from the 22 variants normalized by that of the control 
variant, either during leucine limitation (top panel) or during leucine-rich growth (bottom panel). 
Horizontal axis indicates the location of the CTA codon along each yfp variant (ATG start codon 
= 1). Error bars show standard error over three replicate cultures. 
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Fig. S3. yfp variants have uniform protein synthesis rates when starved for a non-
cognate amino acid. 
Leucine and arginine variants of yfp were expressed in an E. coli strain, CP78 that is auxotrophic 
for both leucine and arginine. Response of the 6 leucine variants to Arg limitation is determined 
by the arginine codons in yfp (CGT and CGC) that are common across all 6 leucine variants. 
Reciprocally, the response of the 6 arginine variants to leucine limitation is determined by the 
leucine codon that is common to the arginine variants of yfp (CTG). YFP synthesis rates are 
defined as in Fig. 1D. Error bars show standard error over three replicate cultures. 
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Fig. S4. Comparison of measured robustness during amino acid limitation with 
codon usage and tRNA concentration. 
(A) Codon usage was calculated as the average frequency of each codon across all protein 
coding sequences in E. coli. (B) tRNA concentration for each codon was calculated as the sum of 
tRNA concentrations for all cognate tRNAs(1). (C) Since tRNAs can differ substantially in their 
affinity for their cognate codons, we also compared the measured robustness against the tRNA 
adaptation index for each codon (2). This index accounts for different affinities for synonymous 
codons for the same tRNA isoacceptor. All three measures along the horizontal axes were 
normalized by the maximum value within each codon family. Robustness to amino acid 
limitation was quantified as the ratio of normalized YFP synthesis rates between amino acid 
limited and amino acid rich growth phases. Error bars represent standard error over three 
replicate cultures. The data points that are not visible for a few codons overlap at the top right-
hand corner of each plot. 
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Fig. S5. Comparison of charged tRNA fraction with robustness of YFP synthesis 
rates during amino acid limited growth. 
To compare YFP synthesis rates with charged tRNA fractions, we first inferred the elongation 
rates for leucine and arginine codons from the measured charged fraction of leucine and arginine 
tRNA isoacceptors (3) (see Appendix). We used previously assigned codon-tRNA assignments 
and kinetic parameters (4). Note that we cannot directly compare charged tRNA fractions with 
synthesis rates of yfp variants due to overlapping and multiple codon assignments for several 
tRNA isoacceptors. Robustness to amino acid limitation was quantified as the ratio of 
normalized YFP synthesis rates between amino acid limited and amino acid rich growth phases. 
Error bars represent standard error over 3 replicate cultures. Relative codon elongation rate is the 
ratio of codon elongation rates between amino acid starved and amino acid rich growth regimes, 
normalized to the maximum value within each synonymous codon family. 
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Fig. S6. Miscoding of a single arginine residue in YFP causes loss of fluorescence. 
To test whether mistranslation of arginine residues can underlie the high residual fluorescence of 
Arg yfp variant - Arg tRNA pairs (AGA: arg3, AGG: arg3, and CGG:arg4, arg5 in Fig. 2B), 
three YFP mutants were created that had one of three single point mutations at Arg 96: R96H, 
R96K, and R96Q. The mutant and the ‘wild-type’ YFP proteins were expressed from a pUC18 
high-copy vector. Each of the three mutations at Arg96 to a chemically similar amino acid (H, K 
or Q) decreased YFP fluorescence to background level (that of an empty pUC18 vector). Error 
bars denote standard deviation over 5 biological replicates. 
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Fig. S7. Histogram of CRI. 
Green and pink data markers correspond to the leucine and arginine CRI values for 4300 ORFs 
in E. coli’s genome. Blue and red data markers correspond respectively to leucine and arginine 
CRI values for the E. coli ORF-yfp fusions respectively that were used to experimentally validate 
CRI. 
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Fig. S8. Arg CRI is positively correlated with measured robustness of 56 E. coli 
ORF–yfp fusions during Arg limitation. 
The yfp sequence used for this experiment had the AGA codon at all Arg codon locations of yfp 
since AGA has the highest wcodon value among arginine codons (see Fig. 3B). Correlation is 
reported as squared Spearman rank correlation. Error bars show standard error over three 
replicate cultures. . Robustness to amino acid limitation was quantified as the ratio of normalized 
YFP synthesis rates between amino acid limited and amino acid rich growth phases. 
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Fig. S9. Protein synthesis rate during amino acid rich growth is weakly correlated 
with measures of translation efficiency under nutrient-rich growth. 
Protein synthesis rates from 92 E. coli ORF-yfp fusions during leucine-rich growth showed only 
a weak correlation with measures of codon adaptation, tRNA adaptation and 5’ folding energy of 
mRNA (see Supplementary Methods). Folding energy was calculated from -5 to +37 nt of the 
ATG codon. Codon adaptation index (CAI) and tRNA adaptation index (tAI) were calculated 
using Biopython and codonR packages. Correlations are reported as squared Spearman rank-
correlation coefficient. 
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Fig. S10. CRI predicts the change in robustness during amino acid limitation due to 
synonymous mutations. 
63 synonymous variants of 13 ORF-yfp fusions were constructed by mutating wild-type TTG or 
TTA codons in the ORF sequence to the codon CTC that causes sensitive protein synthesis rate 
under leucine limitation. The number of mutations was between 1 and 6 and the location of these 
mutations was random. 59 of the 63 variants displayed a decrease in their robustness during 
leucine limitation (dashed lines) that was predicted by leucine CRI (solid lines). In addition, 
magnitude of the changes in robustness during leucine limitation were positively correlated with 
magnitude of the changes in leucine CRI (r
2
 = 0.19, P = 10
-4
). Filled circles indicate values for 
ORFwild-type and open circles indicate values for ORFvariants. Different open circles within a single 
polygon correspond to distinct ORF variants for the same wild-type ORF. . Robustness to amino 
acid limitation was quantified as the ratio of normalized YFP synthesis rates between amino acid 
limited and amino acid rich growth phases. Error bars show standard error over 3 replicate 
cultures. Most error bars are smaller than data markers. DNA sequences for variants are provided 
in gene_sequences.fasta supplementary file. 
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Fig. S11. Synonymous mutations and tRNA co-expression affect expression from E. 
coli ORFs only during amino acid limitation. 
We analyzed the change in protein synthesis rates from the 21 ORF-yfp fusions complemented 
with 
GAG
Leu2 (Fig. 3D) and the 63 different ORF-yfp variants with synonymous mutations (Fig. 
S10). Several of the 
GAG
Leu2-coexpressed as well as the synonymously-mutated ORF-yfp 
variants (84 total variants) had significantly altered protein synthesis rates compared to their non-
tRNA co-expressed or non-mutated counterparts (referred as wild type) during leucine limited 
growth (green histogram, median fold-change in protein synthesis rates = 2.37). By comparison, 
most of the 84 variants had similar protein synthesis rates to their wild-type counterparts during 
leucine rich growth (grey histogram, median fold-change in protein synthesis rates = 1.12). 
Protein synthesis rates were defined as in Fig. 1D. 
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Fig. S12. Synonymous mutations in amino acid biosynthesis genes decrease their 
expression level during amino acid limitation. 
(a) Synthesis rates from leuA, leuC, leuD and carA, argA, argF -yfp fusions encoding either 
wild-type or mutant ORF sequences during amino acid rich and amino acid limited growth. The 
synthesis rates were normalized for each pair of wild-type and mutant ORF-yfp fusions, and also 
for each growth condition. Error bars show standard error over 6 replicate cultures. 
(b) Position and identity of synonymous mutations in wild-type and mutant sequences used for 
the experiment in (A). The black vertical bars correspond to the non-mutated leucine codons in 
the case of leuA, leuC and leuD, and to the non-mutated arginine codons in the case of carA, 
argA and argF. 
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Fig. S13. Correlation of protein synthesis rates with ribosome pausing at serine 
codons during serine-limited growth. 
Protein synthesis rate of serine synonymous variants of yfp during serine limitation (same data as 
in Fig. 1D, third panel) is negatively correlated with genome-wide ribosome occupancy at serine 
codons during serine-limited growth of E. coli. The increased occupancy at perturbation-
sensitive serine codons is consistent with selective ribosome pausing at these codons. Ribosome 
occupancy data was taken from a recent ribosome profiling experiment in E. coli (5).  
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Fig. S14. mRNA level changes of yfp variants in response to cognate amino acid 
limitation. 
We measured the change in mRNA levels of different yfp variants in response to amino acid 
limitation. Total RNA was extracted either during exponential amino acid rich growth or 60 min 
after amino acid limited growth in the presence of the amino acid methyl-ester. mRNA levels 
were quantified by RT-qPCR relative to gapA mRNA (see Supplementary Methods). Error bars 
show standard error of triplicate qPCR measurements. . Synthesis rate robustness to amino acid 
limitation was quantified as the ratio of normalized YFP synthesis rates between amino acid 
limited and amino acid rich growth phases. 
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Fig. S15. Raw absorbance and fluorescence curves with or without methyl-ester 
analog of amino acids. 
Growth and fluorescence curves for two yfp variants corresponding to CTA and CTG codons are 
shown here as representative examples for amino acid limited growth in the presence or absence 
of methyl-ester analogs in the growth medium. Absorbance as measured using spectrometry is 
proportional to cell density. Presence of methyl-ester analogs caused an increase in the time and 
cell density at which amino acid limited growth began. More importantly, inefficient metabolism 
of methyl-ester analogs resulted in a slow but steady growth in amino acid limited regime. This 
residual growth ensured that YFP synthesis continued robustly from the CTG yfp variant under 
these conditions. By contrast, in the absence of methyl-esters in the growth medium, YFP 
synthesis from all yfp variants eventually dropped to zero. 
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Fig. S16. Comparison of two different amino acid limitation protocols: with or 
without methyl-ester analog of amino acids. 
Robustness to amino acid limitation in the absence of methyl-ester analogs was calculated as the 
ratio of fluorescence change between the amino acid limited growth phase and amino acid rich 
growth phase. This ratio was further normalized by the maximum value within each codon 
family. . Robustness to amino acid limitation in the presence of methyl-ester analogs was 
quantified as the ratio of normalized YFP synthesis rates between amino acid limited and amino 
acid rich growth phases. Error bars show standard error over 3 replicate cultures. 
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Fig. S17. Plasmid map of expression vector for yfp and ORF-yfp fusions. 
A specific plasmid construct with yfp0 is shown here. In the case of ORF-yfp fusions, yfp was 
fused in-frame to the 3’-end of the ORF with a GGSGGS hexa-peptide linker sequence that 
encoded a BamHI restriction site and the resulting coding sequence of the fusion protein was 
cloned between the KpnI and HindIII restriction sites in the above vector.  
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Fig. S18. Plasmid map of expression vector for tRNA genes. 
A specific construct encoding an Arg tRNA is shown here.  
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Fig. S19. Reproducibility of measurements between biological replicates of 92 E. coli 
ORF-yfp fusions. 
Two different colonies were picked after cloning the 92 ORF-yfp fusions and the same leucine 
limitation assay that was used for the data in Fig. 3C was performed on these two biological 
replicates on two different days. None of the clones for replicate 2 were sequence-verified and 
hence the few outliers seen above could be the result of errors in the cloned sequences. The data 
reported in Fig. 3C is from replicate 1 for which about 40 constructs were sequence-verified. 
Robustness to leucine limitation was calculated as the ratio of normalized YFP synthesis rates 
between amino acid limited and amino acid rich growth phases.  
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Supplementary Methods 
Bacterial strains 
All strains used in this study were obtained from the E.coli Genetic Stock Center (CGSC), Yale 
University. For amino acid limitation experiments, standard auxotrophic strains (Table S5) were 
used depending on the amino acid that was limiting in the growth medium, unless mentioned 
otherwise. Strain CP78 was used for experiments involving leucine and arginine limitation. This 
strain has been used extensively in previous amino acid limitation studies (3, 6–10) and its 
multiple auxotrophy makes it a convenient choice for experiments involving limitation for 
several amino acids. The auxotrophic strains corresponding to the remaining amino acids are 
from the Keio-knockout collection (11), and are the commonly used auxotrophic strains for that 
amino acid (http://cgsc.biology.yale.edu/Auxotrophs.php). 
For the growth lag measurements in Fig. 4A, the prototrophic strain MG1655 (Table S5) was 
used as the wild-type background. This background strain was tagged with yfp or rfp at the attBλ 
locus (this tagging was a remnant from earlier experiments not related to this work, and has no 
relevance to any results presented here). Site-directed mutagenesis was used to create the 
synonymous mutant coding sequences for leuA, leuC, leuD, carA, argA and argF using the 
protocol outlined in the section on gene synthesis and cloning below. Then to insert these mutant 
ORFs into their native locus without any additional markers, a two-step strategy based on λ Red-
mediated homologous recombination (12) was used: In the first step, the respective wild-type 
ORF was replaced by a kanamycin resistance gene, and in the second step the kanamycin gene 
was replaced by the mutant ORF without any additional markers by selecting on M9-glucose 
plates for prototrophy of the respective amino acid. Plasmid pSIM5 (13) was used as the helper 
plasmid and the recombineering protocol outlined in the original work (13) was used without any 
modifications.  
For the RT-qPCR data shown in Fig. 4B, a leucine auxotroph of MG1655 was created by 
deleting the leuB gene using the λ Red-mediated homologous recombination protocol outlined 
above. 
For the Western blots (Fig. S1), the auxotrophic strains in Table S5 were further modified by 
insertion of the tet repressor gene at the λ-attB site using a previous method based on site-
specific recombination using λ integrase (14). The presence of tet repressor enabled inducible 
control of YFP expression. The Western blots for leucine and arginine yfp variants were 
performed in an MG1655 auxotroph strain background instead of the CP78 strain. The CP78 
strain has lower transformation efficiency which prevented integration of the tet repressor gene 
into the chromosome. 
Strains were stored as 20% glycerol stocks at -80C either in 1ml cryo-vials or in 96-well plates 
(3799, Costar). In addition, for experiments involving over 25 strains, a temporary 20% glycerol 
stock was stored at -20C in 96-well PCR plates. 
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Plasmids 
The pZ series of plasmids(14) were used for final expression of all genes in this study. General 
features of the plasmid backbones are described here. Specific gene constructs that were cloned 
into these backbones is described in the section on gene synthesis and cloning. A low-copy 
plasmid, pZS*11 [SC101* ori (3-4 copies/cell), Amp
R
 (bla gene) and a constitutive PLtetO-1 
promoter] was used for expression of all fluorescent reporter genes and their fusions. The 
synthetic ribosome binding site (RBS) in the original pZS*11 backbone was replaced by a 
modified T7-based RBS that resulted in efficient protein expression from most coding sequences. 
A medium-copy plasmid, pZA32 [p15A ori (10-12 copies/cell), Chl
R
 (cat gene) and PLlacO-1 
promoter] was used for expression of all tRNA genes. Strains with pZA32 plasmids were grown 
with 1mM IPTG to ensure constitutive expression of all tRNA genes. Standard plasmids pUC18 
and pUC19 (Invitrogen) were used as intermediate cloning vectors for site-directed mutagenesis. 
Plasmid pSIM5 (13) was used as the helper plasmid expressing the Red system for all 
chromosomal modifications in this project (except for tet repressor insertion mentioned in the 
previous section on bacterial strains). 
Growth and fluorescence measurements 
Overnight cultures were inoculated either from freshly grown single colonies or, in experiments 
involving more than 25 strains, from temporary glycerol stocks stored at -20C. Overnight 
cultures were grown in a modified MOPS rich-defined medium (15) made with the following 
recipe: 10X MOPS rich buffer, 10X ACGU nucleobase stock and 100X 0.132M K2HPO4 
(Teknova, Cat. No. M2105) were used at 1X final concentration as in the original recipe. In 
addition, the overnight growth medium contained 0.5% glucose as carbon source, 10
-4
% 
thiamine and 800µM of 19 amino acids and 10mM of serine. pH was adjusted to 7.4 using 1M 
NaOH and appropriate selective antibiotics (50µg/ml ampicillin and/or 20µg/ml 
chloramphenicol) were added. Amino acids, glucose, thiamine and antibiotics were purchased 
from Sigma. 1ml overnight cultures were grown in 2ml deep 96-well plates (40002-014, VWR) 
at 30C with shaking at 1350rpm (Titramax 100 shaker) for 12 to 16 hours. 
For experiments involving amino acid limitation, overnight cultures were diluted 1:1000 into 
1ml of the same MOPS rich-defined medium as the overnight cultures. However the amino acid 
whose limitation was to be induced was added at a reduced concentration and supplemented with 
its methyl-ester analog (Table S6). Amino acid methyl-esters are analogs of the corresponding 
amino acids and have been previously used for steady growth of E. coli under amino acid 
limiting conditions(16, 17) (see Figs. S15 and S16 for the effect of methyl-ester on growth and 
robustness of YFP synthesis). Addition of the methyl-esters results in a steady but limiting 
supply of the amino acid due to slow hydrolysis of the ester (see Note S1). Concentrations of the 
amino acid and its methyl-ester were chosen such that the cultures consumed the limiting amino 
acid and entered amino acid-limited growth at an OD600 of 0.6-0.7 (corresponding to an OD600 
value of 0.2-0.25 in our 96-well plate reader). Slight variations in the initial concentration of 
either the limiting amino acid or its methyl-ester shift the transition to a higher or lower cell 
density without appreciable changes in growth rate (see Note S2). Except for a single limiting 
amino acid, the remaining 19 amino acids were present at the overnight culture concentrations 
during the amino acid limitation experiments. For proline limitation, no proline was necessary in 
43 
 
the growth medium since proline methyl-ester supported growth at the same rate as proline until 
the OD600 reached around 0.6. 
Diluted overnight cultures were grown in 2ml deep 96-well plates for 3 hours at 30C with 
shaking at 1350rpm (Titramax 100 shaker). After this time interval, 3 aliquots of 150µl each 
from each culture was pipetted into 3 wells of 3 different 96-well plates (3799, Costar). Wallac 
Victor2 plate reader (PerkinElmer) was used to monitor cell density (absorbance at 600nm) and 
YFP synthesis (fluorescence, excitation 504nm and emission 540nm). Each plate was read every 
15 min using a robotic system (Caliper Life Sciences) and shaken in between readings 
(Variomag Teleshake shaker) for a total period of 6-10 hours. Temperature of 30C and relative 
humidity of 60% was maintained throughout the experiment. 
In the case of experiments without methyl-ester (Figs. S15 and S16), the exact same protocol 
mentioned above was followed but the methyl-esters were not added to the growth medium. 
For the RT-qPCR measurements shown in Fig. 4B, overnights cultures were diluted 1:1000 into 
the same medium. Then when the OD600 reached 0.5, the cells were spun down at 3000g for 5 
min and then re-suspended in the same medium but either with or without leucine. Total RNA 
was extracted (see protocol below) after 30 min of shaking at 30C, 200rpm. 
For the growth lag measurements shown in Fig. 4A, overnight cultures of prototrophic strains 
were diluted 1:200 into medium either with or without one of leucine and arginine. Growth lag 
was measured as the difference in time taken to reach OD600 of 0.3 between two cultures of the 
same strain – one growing in the presence of an amino acid and another growing in its absence. 
Gene synthesis and cloning 
All gene sequences constructed for this study are provided in the gene_sequences.fasta file. The 
plasmid backbone sequences are provided in the plasmid_sequences.genbank file. Primer 
sequences used for cloning will be provided upon request but in almost all cases, 18 to 22bp 
homologies without any special primer design criteria were sufficient for successful PCR 
amplification. 
Initial yfp construct 
All yfp variants used in this study were modified starting from a single yellow fluorescent protein 
gene sequence (called yfp0 in the sequence file and plasmid map). This yfp0 sequence encodes 
the fast-maturing ‘Venus’ variant of YFP (18). All 238 codons of yfp0 were chosen such that 
they were read by abundant tRNA isoacceptors for each amino acid. Such a choice of codons 
ensured that the native level of demand for each tRNA isoacceptor inside the cell was minimally 
perturbed by the low-copy expression of fluorescent reporter genes. The yfp0 sequence was built 
de novo (synthesis by Genscript, USA). The synthesized yfp0 sequence was cloned between the 
KpnI and HindIII restriction sites of the pZS*11 plasmid vector using standard molecular-biology 
techniques (19). The plasmid map of the resulting construct, pZS*11-yfp0 is shown in Fig. S17. 
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Synonymous variants of yfp 
A subset of codons in yfp0 corresponding to 7 amino acids (Leu, Arg, Ser, Pro, Ile, Gln, Phe) 
were mutated to create the initial 29 synonymous variants of yfp (yfp1 – yfp29 in the 
gene_sequences.fasta file, sequences in the same order as shown in Fig. 1A). The 4 yfp variants 
corresponding to Pro (yfp19-yfp22) had all the Pro codons mutated to the most frequent CCG 
codon since the original yfp0 sequence had a few CCA and CCT codons that are more sensitive 
to Pro limitation. Similarly, all the Phe codons in yfp0 were mutated to the most abundant Phe 
codon TTT for the two Phe variants of yfp0 (yfp28-yfp29). Both these groups of variants (6 total) 
had higher overall fluorescence during amino-acid rich conditions than the rest of the 23 
variants. This higher fluorescence is likely due to changes in secondary structure near the 
ribosome binding region on the mRNA as a consequence of mutations near ATG. However, this 
change is common across all variants within the Pro and Phe synonymous codon groups and 
hence is not responsible for the differential response to cognate amino acid limitation measured 
within these synonymous codon groups. 
For constructing the 29 yfp variants, yfp0 from pZS*11-yfp0 was first cloned into a pUC19 
cloning vector between the KpnI and HindIII restriction sites. A commercial site-directed 
mutagenesis kit (Quickchange Lightening Multi, Applied Biosystems) was used to introduce the 
mutations corresponding to each of the 29 variants and the manufacturer’s protocol was 
followed. The resulting variants were verified by Sanger sequencing and then cloned into the 
pZS*11 expression vector backbone between the KpnI and HindIII sites. The 22 single CTA 
variants of yfp (Fig. S2) were constructed using the same procedure as above. The 29 yfp variants 
for Western blotting (Fig. S1) were created using the same procedure as above, but with the 
addition of a 22 codon sequence at the 5’ end that encoded a 3X-FLAG peptide recognized by a 
commercially available, anti-FLAG, antibody (Sigma). The 22-codon sequence is: 
GACTACAAAGACCATGACGGTGATTATAAAGATCATGACATCGACTACAAGGATGA
CGATGACAAG. 
tRNA expression vectors 
The 5 distinct Leu tRNA isoacceptors encoded by the genes leuQ, leuU, leuW, leuX and leuZ, 
and the 4 distinct Arg tRNA isoacceptors encoded by the genes argV, argX, argU and argW 
were cloned between the EcoRI and HindIII sites of the pZA32 expression vector (Fig. S18). 
These genes were amplified by PCR from the chromosome of E. coli strain MG1655. In addition 
to these native tRNA genes, a synthetic tRNA gene arg2m that was cognate to the CGA Arg 
codon was also created. Normally, the 
ACG
Arg2 tRNA with ICG anti-codon reads the CGA 
codon inefficiently through a purine-purine wobble pairing . Expressing a synthetic tRNA with 
an anticodon UCG restores efficient reading of this codon and is equivalent to increasing the 
supply of the corresponding cognate tRNA isoacceptor. This synthetic tRNA isoacceptor was 
created from the pZA32-argV expression vector by using overlap PCR to introduce the necessary 
single bp mutation in the anticodon of argV. The pZA32 vectors with the tRNA genes were 
electroporated into strains already containing the yfp expression vectors. 
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Library of E. coli ORF-yfp fusions 
92 E. coli Open Reading Frames (ORFs) were selected for experimental validation of the Leu 
codon robustness index (Leu CRI). These ORFs were chosen to span a wide range of predicted 
Leu CRI values and functional categories (Fig. S7 and Table S1). First, a modified pZS*11-yfp0 
vector backbone was created in which the start codon of yfp0 was replaced by a GGSGGS hexa-
peptide linker sequence: GGTGGATCCGGCGGTTCT containing a BamHI restriction site. 
Next, the 92 ORFs (without the stop codon) were amplified by PCR from the chromosome of E. 
coli strain MG1655 with 5’-KpnI and 3’-BamHI restriction site overhangs. These PCR fragments 
were cloned into the modified pZS*11-yfp0 vector backbone containing the BamHI restriction 
site. 13 of the 92 ORFs had either an internal KpnI or an internal BamHI site. In these cases, a 
larger fragment that included adjoining sections of the pZS*11-yfp0 vector was constructed by 
overlap PCR and then cloned using other restriction sites (EcoRI or HindIII). Thus the final 
constructs had one of the 92 E. coli ORFs connected through a hexapeptide linker with yfp0. All 
the cloned sequences were verified by PCR for inserts of right length and 25 of the ORF 
constructs were verified by Sanger sequencing. Two biological replicates of each ORF construct 
were compared for their synthesis robustness values as measured during the amino acid 
limitation assay and these values showed a high degree of correlation (Pearson ρ = 0.93, Fig. 
S19). 
For validating the Arg codon robustness index (Arg CRI), 56 E. coli ORFs that included a subset 
of the above 92 ORFs were chosen (Table S2). The cloning procedure was exactly analogous to 
the above 92 ORFs but with one difference: the yfp0 part of the fusion construct was replaced by 
a synonymous variant of yfp0 (yfp7) that had the Arg codon AGA instead of the CGT and CGC 
codons in the yfp0 sequence. The codon AGA has the highest wcodon value among the Arg codons 
(see Fig. 3B) and hence has a minimal effect on the measured robustness of the ORF fusions 
during Arg limitation. 
GAGLeu2-tRNA co-expression with E. coli ORF-yfp fusions 
Out of the 92 E. coli ORF-yfp fusions, 21 were chosen for co-expression with the 
GAG
Leu2 tRNA 
that is cognate to the codons CTC and CTT. The 21 ORFs were chosen such that 11 of them had 
a lower Leu CRI prediction than their wild-type counterparts while the other 10 ORFs had a 
higher Leu CRI prediction than their wild-type counterparts. This choice also corresponded 
respectively to either high frequency of the non-cognate TTA and TTG codons for 
GAG
Leu2 or 
high frequency of the cognate codons CTC and CTT. The strains containing the 21 ORF fusions 
were each made electro-competent and then transformed with the pZA32-leuU plasmid that 
expresses 
GAG
Leu2.  
Synonymous variants of E. coli ORF-yfp fusions 
Out of the 92 E. coli ORF-yfp fusions, 13 were selected for creating synonymous mutants. These 
13 ORFs had a high frequency of one or both of the Leu codons, TTA or TTG and these codons 
were mutated to the Leu codon, CTC. All these 3 codons, TTA, TTG and CTC occur at similar 
frequencies on average across the genome of E. coli. Hence mutating between these codons will 
not significantly change either the codon adaptation index (CAI) or the tRNA adaptation index 
(tAI). The 13 ORF-yfp fusions were amplified by PCR from the pZS*11 vectors between the 
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EcoRI and XbaI restriction sites (see Fig. S17). These fragments were cloned between EcoRI and 
XbaI sites of the pUC19 cloning vector. A commercial site-directed mutagenesis kit 
(Quickchange Lightening Multi, Applied Biosystems) was used to introduce the TTA, TTG  
CTC mutations. A unique primer was designed for each of the TTG or TTA codons in the 13 
ORFs and the primers encoded the CTC mutation. All the primers corresponding to each ORF 
were mixed and then used in the mutagenesis reaction. This procedure resulted in mutant coding 
sequences with TTA, TTG - > CTC mutations at random locations. 10 colonies for each ORF 
were sequenced and each unique mutant sequence was then cloned into the pZS*11 expression 
vector. At the end of the procedure, a total of 63 constructs were created that each had between 
one and seven TTA, TTG -> CTC mutations (see gene_sequences.fasta file for exact sequences). 
Total RNA extraction 
Total RNA was extracted for two different experiments (Figs. 4B, S14). Phenol-chloroform 
extraction method was used to obtain total RNA. Briefly, 3ml of cells were quickly mixed with 
5ml of ice-cold water and harvested by centrifugation at 3000g for 10min. Cell pellets were re-
suspended in 500 µl of 0.3M sodium acetate- 10mM EDTA pH 4.8 buffer. The re-suspended 
µl of acetate-saturated phenol- µl of 20% SDS 
and 500 µl of acid-washed glass beads (G1277, Sigma). The mixture was shaken in a vortexer 
for 20 min at 4C. The aqueous layer was extracted twice with acetate-saturated phenol –
chloroform at pH 4.8 and once with chloroform. Total RNA was precipitated with an equal 
volume of isopropanol and washed with 70% ethanol –50mM sodium acetate pH 4.8 and finally 
re- µl of RNase-free w µl of the total RNA was treated with DNase 
(EN0521, Fermentas) to remove residual DNA contamination (manufacturer’s instructions were 
followed). The DNA-free RNA was re- µl of RNase-free water. Intact RNA was 
confirmed by observation of sharp rRNA bands in native agarose gel electrophoresis. 
RT-qPCR measurement 
µl of the DNA-free RNA (100-200ng) and 
Maxima reverse transcription kit (K1641, Fermentas), used according to the manufacturer’s 
instructions. Random hexamer primers were used for priming the RT reaction. At the end of the 
µl reaction was diluted 100- µl of this diluted sample was used for 
qPCR in the next step. qPCR was performed using Maxima SYBR-Green qPCR kit (K0221, 
Fermentas) and manufacturer’s instructions were followed. qPCR was performed in triplicates 
for each RT reaction and appropriate negative RT controls were used to confirm the absence of 
DNA contamination. gapA mRNA was used as internal reference to normalize all other mRNA 
levels. Standard curves with 6 serial dilutions were used to optimize reaction conditions and 
ensure amplification efficiency of between 90-100% for the yfp and gapA amplicons. ΔΔCt 
method was used to obtain the change in mRNA levels due to amino acid limitation. The qPCR 
primer sequences are given in Table S8. 
Western blotting 
Fresh colonies were used to inoculate overnight cultures. These overnight cultures were then 
diluted 1:100 into 1ml of rich-defined medium with all 20 amino acids (see section on growth 
and fluorescence measurements for media composition). After approximately 3.5 hours of 
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growth at 30C when OD600 was ~0.4, cells were spun down at 9000g for 1 min, and then re-
suspended in 1ml of rich-defined medium without the amino acid whose limitation was to be 
induced. This re-suspended culture was then split into two equal aliquots. The limiting amino 
acid was added to one aliquot (as a rich-medium control) while the other aliquot did not have the 
limiting amino acid. The re-suspended medium also contained 200ng/ml of anhydro-tetracycline 
in order to induce the pLtet-O1 promoter that controls the 3XFLAG-yfp variants. After growth at 
30C for 60 min, cells were spun down at 12000g, 1 min and re-suspended in 40-400ul of 
CellLytic B buffer (Sigma, B7435). The buffer volume used was proportional to the OD600 
measured at the time of harvesting the culture. The lysate was stored at -80C. 10ul of the lysate 
was mixed with 2X Laemmli Buffer (Biorad) and then loaded onto each lane of a pre-cast 
polyacrylamide gel (Biorad) and SDS-PAGE was carried out at 100V for 120 min. Proteins were 
transferred to a nitrocellulose membrane by semi-dry blotting at 180mA for 60 min. The 
membrane was blocked in 2% skim-milk-TBST overnight, and then incubated with a 1:2000 
dilution of an anti-FLAG antibody (F3165, Sigma) in 2% skim-milk-TBST with shaking at room 
temperature for 90 min. After washing 4 times for 5 min with TBST, the membrane was 
incubated with 1:2000 dilution of a secondary HRP-conjugated antibody (7076, Cell Signaling) in 
2% skim-milk-TBST with shaking at room temperature for 60 min. After washing 4 times for 5 
min with TBST, the membrane was treated with an HRP substrate (L00354, Genscript) for 5 min 
and exposed for 30s to a luminescence imager. 
Analyses – data, models, bioinformatics 
Matlab R2009b (Mathworks) was used for all analyses unless otherwise mentioned. All 
correlations and P-values reported in this work were calculated using the Matlab command ‘corr’ 
with the ‘Type’ option set to either ‘Spearman’ or ‘Pearson’ as appropriate. 
Growth and fluorescence analysis 
Background absorbance and fluorescence values (obtained from wells containing only growth 
media) were subtracted from the measured time series for each well. An exponential curve was 
fitted to the amino acid-rich growth regime for all data points located at least 50 min before the 
onset of amino acid limitation. A straight line was fitted to the amino acid-limited growth regime 
for all data points located at least 50 min after the onset time. These fits were performed using 
the Matlab command ‘fit’, and the in-built library options ‘Exp1’ and ‘Poly1’ respectively. To 
automatically identify the onset time, the intersection point between the two fitted curves was 
designated as the onset time of amino acid limitation. This inferred onset time coincided with the 
onset time identified through visual inspection of the growth curves. 
To minimize noise in calculated protein synthesis rates, an exponential curve was fitted to the 
amino acid-rich regime of the fluorescence time-series and a straight line was fitted to the amino 
acid-limited regime of the fluorescence time-series. These fits were performed using the Matlab 
command ‘fit’, and the in-built library options ‘Exp1’ and ‘Poly1’ respectively. Protein synthesis 
rate, S was calculated as: 
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First, the above formula was evaluated at the onset time of amino acid limitation using the 
exponential fits for absorbance and fluorescence data in the amino acid rich growth regime. 
Next, the same formula was evaluated at the onset time using the linear fits for absorbance and 
fluorescence data in the amino acid limited growth regime. These two values correspond to the 
protein synthesis rates reported for the amino acid rich and amino acid limited growth regimes 
(such as the data in Fig. 1D). The protein synthesis rates were normalized within each 
synonymous codon family and for each growth condition. Robustness of protein synthesis to 
amino acid limitation was calculated as the ratio of normalized protein synthesis rates between 
the amino acid rich and amino acid limited growth regimes. 
In the case of the experiment without methyl-ester (Fig. S15 and Fig. S16), the onset time of 
amino acid limited growth was determined exactly as above. Then starvation robustness was 
calculated as the normalized ratio of total fluorescence increase after the onset of amino acid 
limited growth to the fluorescence increase before this onset. Total fluorescence increase rather 
than protein synthesis rate was used for this analysis since protein synthesis rates without 
methyl-ester decreased continuously to zero after the onset of amino acid limited growth. 
Calculation of CRI (Fig. 3) 
CRI for a protein coding sequence corresponding to a limiting amino acid was calculated by 
multiplying the wi weights for codons cognate to the limiting amino acid in that sequence. wi 
values that are shown in Fig. 3B were calculated using the robustness of protein synthesis of the 
corresponding yfp variants during cognate amino acid limitation (Fig. 1D). Based on our non-
cognate limitation experiment (Fig. S3), the wi values for all codons other than those cognate to 
the limiting amino acid are set to be equal to 1. 
For illustration, we demonstrate the calculation of wi for the 6 leucine codons below. The exact 
same procedure was followed for other synonymous codon families. Taking  for 
each codon, and  for each yfp variant,  
   
   
   
  
  
  
The multiplicative factors on the LHS in front of Wi correspond to the number of different 
leucine codons in the corresponding leucine variant of yfp (see Fig. 1A, left panel). The RHS is 
the measured (log2) robustness of protein synthesis from the corresponding yfp variant during 
leucine limitation (see Fig. 1D, top left panel). These equations were solved simultaneously to 
determine the wi value for each leucine codon. Revised wi values (Table S7) based on yfp 
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measurements in the presence of 
GAG
Leu2 tRNA were used for calculation of leucine CRI in the 
case of 
GAG
Leu2 tRNA co-expression with E. coli ORFs (Fig. 3D). 
Leu and Arg CRI for E. coli ORFs (Fig. 3) 
4300 ORF sequences for E. coli were parsed out from the MG1655 genome sequence (NCBI 
website, Accession number: NC_000913, downloaded on 14
th
 Apr 2011). For each of these 4300 
E. coli ORFs, Leu or Arg CRI was calculated by multiplying the wi values for either all Leu or 
all Arg codons respectively in the ORF sequence. For the 63 synonymous variants of 13 ORFs 
(Fig. S10), Leu CRI values were calculated using the same procedure as above after accounting 
for the synonymous mutations. For the 21 ORFs co-expressed with Leu2 tRNA (Fig. 3D), 
revised wi values were first calculated using the method outlined in the previous section (Table 
S7), and using measurements on the 6 Leu variants of yfp complemented with 
GAG
Leu2 tRNA(3
rd
 
column in Fig. 2A). These revised wi values were then used to calculate Leu CRI under tRNA 
co-expression for the 21 tRNA co-expressed ORFs applying the same procedure as for the non-
co expressed case. 
Z-score for codon robustness index (Fig. 4B) 
To quantify the deviation in codon robustness index from its expected value for each of the 4300 
ORFs in the E. coli genome, 1000 random coding sequences were generated for each ORF. Each 
random version preserved the original amino acid sequence, but the codons for a single amino 
acid were sampled randomly from a multinomial distribution based on the average frequency of 
codons for that amino acid across the genome. CRI values were calculated for each random 
version of the gene, and a distribution of CRI values were generated from the 1000 random trials. 
The average, µCRI and standard deviation, σCRI of this CRI distribution was used to calculate the 
Z-score for CRI as follows: 
 
In the case of the Z-score for leucine shown in Fig. 4B, the leucine codon CTG was not 
randomized in the above calculation and only the remaining 5 leucine codons: CTA, CTC, CTT, 
TTA, and TTG were randomized based on their genome-wide codon frequencies. This step is 
essential since CTG, which is read by an abundant tRNA isoacceptor, is enriched in highly-
expressed genes and such genes will show up falsely as perturbation-robust genes because CTG 
is also the codon that is most robust to leucine limitation in our experiments (see Fig. 1D). 
Codon-specific bioinformatic measures (Figs. S4 and S5) 
Codon usage (Fig. S4A) was calculated as the average frequency of each codon across the 
genome of E. coli MG1655 (4300 ORFs). 
tRNA concentrations (Fig. S4B) were taken from previous work(1) (see Table 2). Concentrations 
of all cognate tRNAs for each codon were summed together. 
50 
 
The codon-tRNA adaptation index (Fig. S4C) is taken from literature ((20), see Table S2). The 
tAI value for the CGA codon was revised from the unrealistically low value of 0.00005 to 0.1333 
as explained previously (21). 
For inferring codon elongation rates from charged tRNA fractions (Fig. S5), we used the formula 
for codon elongation rate from (4): 
 
where  is the elongation rate of codon ,  is the codon-independent elongation time across 
any codon,  is the concentration of tRNA isoacceptor  that is cognate to codon ,  is the 
second-order rate constant for binding of the ternary complex containing the charged isoacceptor 
 to the ribosome at codon , and  is the charged fraction of isoacceptor . We calculated the 
codon elongation rates during amino acid limitation using the measured charged fractions from 
(3). For amino acid rich conditions, we set the charged fraction to be equal to unity. We used 
 , and  similar to (4). The ratio of codon elongation rates 
was then normalized within each codon family by the maximum value within that family. 
ORF-specific bioinformatic measures (Fig. S9) 
The measured protein synthesis rates of the 92 E. coli ORF-yfp fusions during amino acid rich 
growth is compared against different bioinformatic measures in Fig. S9. 
Codon Adaptation Index was calculated for each E. coli ORF using the method in (22). This 
calculation was implemented using the CodonAdaptationIndex class in the CodonUsage module 
of BioPython (version 1.58). 
tRNA Adaptation Index was calculated for each E. coli ORF using the method in (2). This 
calculation was implemented using the codonR package 
(http://people.cryst.bbk.ac.uk/~fdosr01/tAI/index.html, downloaded on 3
rd
 Sep 2011). 
mRNA folding energy was calculated for the first 37nt of each E. coli ORF together with the 5 
upstream nucleotides in the pZS11 plasmid backbone (GTACC). Calculation was implemented 
using the hybrid-ss-min command in UNAFold software (23) assuming default parameter values 
for reaction conditions (version 3.8, NA = RNA, T = 37, [Na+] = 1, [Mg++] = 0, maxloop = 30). 
 
Supplementary Notes 
S1. Why do we use methyl-esters in our amino acid limitation experiments? 
Before we settled on the methyl-ester analog-based experiments, we tested two other amino acid 
limitation assays that are commonly used in the literature.  
The first assay is a spin → wash → resuspend in amino acid+ / amino acid- medium (3). We did 
not pursue this assay for most of our experiments since it is logistically difficult to perform this 
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assay when working simultaneously with more than a dozen strains. However, we used this assay 
for the Western blotting and RT-qPCR measurements on a few strains (Fig. S1 and Fig. 4B). 
The second assay involves starting with a low initial concentration of an amino acid and letting 
the bacterial cultures exhaust the amino acid in the medium through exponential growth(24). The 
bacteria then then enter the amino acid limited regime in mid-log phase without any intervention 
from the experimenter. However in the absence of exogenous sources of amino acid in the amino 
acid limited regime, protein synthesis occurs only transiently for less than an hour under these 
conditions and YFP synthesis rates from all yfp variants drop below measurable levels at the end 
of this time period (Fig. S15). More importantly, there is no extended steady state during which 
differential protein synthesis rates can be measured accurately. Nevertheless, we have confirmed 
that the measurements with and without methyl-esters give qualitatively similar results (Fig. 
S16). In addition, Western blotting done in the absence of methyl-ester reproduced the large 
difference in protein levels between synonymous variants of YFP during amino acid limitation 
(Fig. S1). 
In contrast to the assay without methyl-ester, presence of methyl-ester analogs in the growth 
medium results in a quasi-steady state of amino acid limited growth due to hydrolysis of the ester 
during which differential YFP expression can be measured easily (Fig. S15). Such partial amino 
acid limited growth is also likely to be the relevant scenario when prototrophic strains run out of 
amino acids in their growth media and have a limited supply of amino acids through protein 
degradation or partially up-regulated biosynthesis pathways. 
S2. What is the effect of varying the initial concentrations of amino acids and methyl-esters in 
our amino acid limitation assay? 
Increasing the initial concentration of the amino acid or its methyl-ester results in a higher cell 
density for the onset of amino acid limitation, and when the corresponding concentrations are 
decreased, this onset happens at a lower cell density. Importantly, the observed differential 
robustness of protein synthesis (such as the data shown in Fig. 1D) is qualitatively the same upon 
2-fold changes to the initial concentration of either the amino acid or its methyl-ester. As an 
extreme example, see Figs. S15 and S16 for comparison between the cases with and without 
methyl-ester analog in the growth medium.  
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Supplementary Tables 
Table S1: 92 ORF-yfp fusions used for Leu CRI validation 
Genes are arranged by increasing values of Leu CRI. SLeu-rich and SLeu-limited refer to respective 
protein synthesis rates (a.u. per sec per cell). Robustness refers to the ratio between the two 
protein synthesis rates after normalization by the corresponding value for the CTG variant of yfp 
(which is the yfp tag in these ORF-yfp fusions). ± refers to standard error of measurement.  
Gene SLeu-rich SLeu-limited Robustness  
log2 
Leu CRI 
Gene product 
 polB 10.4 ± 0.3  0.6 ± 0.6 0.063 ± 0.062 -19.45 DNA polymerase II  
 thiH 69.7 ± 1.1 -0.7 ± 0.8 -0.012 ± 0.013 -14.52 
tyrosine lyase, involved in thiamin-
thiazolemoiety synthesis  
 aat 26.7 ± 0.8  1.3 ± 0.3 0.054 ± 0.015 -12.52 
leucyl/phenylalanyl-tRNA-protein 
transferase  
 gdhA 20.4 ± 0.3 -0.2 ± 0.2 -0.013 ± 0.009 -11.62 
glutamate dehydrogenase, NADP-
specific  
 serC 91.3 ± 0.5 -1.7 ± 0.6 -0.020 ± 0.008 -11.60 
3-
phosphoserine/phosphohydroxythreo
nineaminotransferase  
 gpsA 111.8 ± 3.3  1.9 ± 1.9 0.020 ± 0.018 -11.38 
glycerol-3-phosphate dehydrogenase 
(NAD+)  
 mlrA 44.1 ± 1.5 -0.7 ± 0.8 -0.017 ± 0.019 -11.09 DNA-binding transcriptional regulator  
 ybeU 41.5 ± 7.6  0.5 ± 0.3 0.017 ± 0.013 -11.00 conserved protein, DUF1266 family  
 argS 67.6 ± 1.9  1.0 ± 0.6 0.017 ± 0.010 -10.93 arginyl-tRNA synthetase  
 ilvD 59.2 ± 5.6  3.4 ± 0.9 0.064 ± 0.017 -10.39 dihydroxyacid dehydratase  
 ugpC 88.5 ± 2.7  1.9 ± 0.9 0.023 ± 0.011 -10.33 
glycerol-3-phosphate transporter 
subunit  
 argI 44.5 ± 4.5  5.3 ± 2.6 0.138 ± 0.067 -10.24 ornithine carbamoyltransferase 1  
 ttdA 86.1 ± 0.2 -0.0 ± 0.5 -0.000 ± 0.006 -10.06 L-tartrate dehydratase, alpha subunit  
 leuS 143.4 ± 3.7 -2.5 ± 0.5 -0.019 ± 0.003 -9.46 leucyl-tRNA synthetase  
 hisB 119.8 ± 3.7 -0.3 ± 3.0 -0.002 ± 0.027 -9.31 
fusedhistidinol-
phosphatase/imidazoleglycerol-
phosphatedehydratase  
 rpoA 71.8 ± 7.5  0.0 ± 0.6 -0.001 ± 0.009 -9.05 RNA polymerase, alpha subunit  
 uvrY 173.2 ± 8.8 -5.2 ± 9.3 -0.027 ± 0.061 -8.36 
DNA-binding response regulator in 
two-componentregulatory system 
with BarA  
 rob 24.9 ± 0.7  0.5 ± 0.2 0.024 ± 0.007 -7.94 
right oriC-binding transcriptional 
activator,AraC family  
 agaS 73.0 ± 3.3  1.3 ± 0.4 0.019 ± 0.005 -7.48 
tagatose-6-phosphate ketose/aldose 
isomerase  
 lysS 111.8 ± 4.4  3.7 ± 2.1 0.035 ± 0.020 -7.17 lysine tRNA synthetase, constitutive  
 sdaB 121.0 ± 5.7 36.4 ± 4.1 0.333 ± 0.044 -7.14 L-serine deaminase II  
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 purA 35.5 ± 2.2 -1.2 ± 0.4 -0.039 ± 0.015 -7.12 adenylosuccinate synthetase  
 rpoD 77.5 ± 2.2  2.3 ± 1.1 0.032 ± 0.014 -6.99 
RNA polymerase, sigma 70 (sigma D) 
factor  
 melR 44.5 ± 3.3 15.1 ± 0.4 0.378 ± 0.031 -6.76 
DNA-binding transcriptional dual 
regulator  
 kefF 99.2 ± 3.0  3.3 ± 0.5 0.038 ± 0.007 -6.52 
flavoprotein subunit for the KefC 
potassiumefflux system  
 uhpA 22.4 ± 1.5  0.4 ± 0.7 0.019 ± 0.034 -6.50 
DNA-binding response regulator in 
two-componentregulatory system 
wtih UhpB  
 ydcN 41.6 ± 2.7  1.9 ± 0.7 0.050 ± 0.015 -6.50 
predicted DNA-binding transcriptional 
regulator  
 aspS 62.3 ± 4.2 10.9 ± 1.5 0.191 ± 0.014 -6.42 aspartyl-tRNA synthetase  
 relB 87.9 ± 2.3  0.8 ± 0.9 0.009 ± 0.010 -6.09 
Qin prophage; bifunctional antitoxin of 
theRelE-RelB toxin-antitoxin system/ 
transcriptionalrepressor  
 guaA 122.6 ± 2.3  6.9 ± 2.2 0.061 ± 0.019 -5.81 
GMP synthetase (glutamine 
aminotransferase)  
phnM 203.7 ± 9.5 20.9 ± 1.2 0.113 ± 0.007 -5.81 
carbon-phosphorus lyase complex 
subunit  
 tdcD  4.5 ± 0.4  7.1 ± 0.2 1.755 ± 0.163 -5.76 
propionate kinase/acetate kinase C, 
anaerobic  
 ompR 114.2 ± 18.7 -1.4 ± 2.2 -0.019 ± 0.027 -5.74 
DNA-binding response regulator in 
two-componentregulatory system 
with EnvZ  
 phnL 75.7 ± 5.3  5.7 ± 1.1 0.082 ± 0.013 -5.51 
carbon-phosphorus lyase complex 
subunit  
 purH 29.6 ± 1.4 10.2 ± 0.4 0.383 ± 0.025 -5.27 
fused 
IMPcyclohydrolase/phosphoribosylami
noimidazolecarboxamideformyltransfe
rase  
 argG  2.5 ± 0.2  3.0 ± 0.2 1.343 ± 0.150 -5.07 argininosuccinate synthetase  
 rimM 107.5 ± 3.7 13.3 ± 0.9 0.137 ± 0.014 -4.95 16S rRNA processing protein  
 ubiC 93.6 ± 3.9  7.5 ± 2.2 0.087 ± 0.022 -4.87 chorismate--pyruvate lyase  
 leuL 48.9 ± 2.3  0.7 ± 0.5 0.017 ± 0.011 -4.75 leu operon leader peptide  
 asnS  9.0 ± 0.4  7.2 ± 0.5 0.884 ± 0.071 -4.65 asparaginyl tRNA synthetase  
 ribB 107.6 ± 7.8 12.2 ± 1.0 0.127 ± 0.020 -4.49 
3,4-dihydroxy-2-butanone-4-
phosphate synthase  
 smpB 15.8 ± 0.8  1.5 ± 0.4 0.101 ± 0.023 -4.39 trans-translation protein  
 guaB 31.0 ± 0.3  5.2 ± 0.6 0.184 ± 0.022 -4.21 IMP dehydrogenase  
 proC 69.2 ± 3.1  9.4 ± 1.6 0.151 ± 0.030 -3.92 
pyrroline-5-carboxylate 
reductase,NAD(P)-binding  
 pth 89.0 ± 2.6 25.2 ± 0.9 0.313 ± 0.018 -3.10 peptidyl-tRNA hydrolase  
 ivbL  1.8 ± 0.3  1.6 ± 0.1 1.085 ± 0.295 -2.89 ilvB operon leader peptide  
 chbR 25.6 ± 1.0 24.4 ± 0.8 1.054 ± 0.008 -2.81 
rRepressor, chb operon forN,N'-
diacetylchitobiose utilization  
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 leuA 78.1 ± 2.2 53.6 ± 0.8 0.756 ± 0.019 -2.77 2-isopropylmalate synthase  
 argD 85.7 ± 4.4 51.0 ± 1.8 0.657 ± 0.031 -2.72 
bifunctional acetylornithine 
aminotransferase/succinyldiaminopim
elate aminotransferase  
 yfcN 98.8 ± 2.1 24.2 ± 1.5 0.270 ± 0.011 -2.71 conserved protein  
 ygiD  7.3 ± 0.3  9.9 ± 0.4 1.503 ± 0.046 -2.62 predicted dioxygenase, LigB family  
 mdtJ 12.5 ± 1.6 17.5 ± 0.2 1.595 ± 0.204 -2.52 multidrug efflux system transporter  
 agaR 80.6 ± 2.5 31.4 ± 2.0 0.428 ± 0.018 -2.39 
DNA-binding transcriptional repressor 
of the aga regulon  
 hisA 22.0 ± 0.9 27.6 ± 0.9 1.392 ± 0.087 -1.86 
N-(5'-phospho-L-ribosyl-formimino)-5-
amino-1-(5'-phosphoribosyl)-4-
imidazolecarboxamide isomerase  
 ygbF 72.7 ± 21.5 26.4 ± 1.3 0.475 ± 0.130 -1.65 
probable ssRNA endonuclease, CRISP-
associatedprotein  
 rpoH 89.2 ± 1.8 50.5 ± 0.9 0.623 ± 0.005 -1.53 
RNA polymerase, sigma 32 (sigma H) 
factor  
 leuD 128.4 ± 2.7 70.0 ± 0.6 0.601 ± 0.018 -1.48 
3-isopropylmalate dehydratase small 
subunit  
 dinJ 58.9 ± 2.8 34.4 ± 1.5 0.648 ± 0.050 -1.48 
antitoxin of YafQ-DinJ toxin-antitoxin 
system  
 nuoI 25.2 ± 1.8 30.6 ± 1.4 1.361 ± 0.164 -1.48 
NADH:ubiquinone oxidoreductase, 
chain I  
 luxS 109.5 ± 0.7 70.3 ± 3.9 0.706 ± 0.035 -1.34 S-ribosylhomocysteine lyase  
 leuC 104.5 ± 6.0 54.0 ± 3.4 0.573 ± 0.069 -1.18 
3-isopropylmalate dehydratase large 
subunit  
 pspA 69.8 ± 2.6 51.4 ± 0.6 0.813 ± 0.039 -1.18 
regulatory protein for phage-shock-
proteinoperon  
 pyrI 138.9 ± 13.7 112.5 ± 6.2 0.906 ± 0.091 -1.15 
aspartate carbamoyltransferase, 
regulatorysubunit  
 btuE 149.1 ± 4.6 132.9 ± 3.6 0.982 ± 0.020 -0.95 glutathione peroxidase  
 msrB 153.6 ± 14.7 131.7 ± 2.8 0.958 ± 0.074 -0.80 methionine sulfoxide reductase B  
 coaD 94.4 ± 0.3 96.2 ± 0.8 1.122 ± 0.012 -0.71 
pantetheine-phosphate 
adenylyltransferase  
 sfsB 72.2 ± 2.4 18.9 ± 1.5 0.291 ± 0.032 -0.61 
DNA-binding transcriptional activator 
of maltosemetabolism  
 nirD 113.2 ± 17.8 22.1 ± 1.5 0.223 ± 0.027 -0.52 
nitrite reductase, NAD(P)H-binding, 
smallsubunit  
 fdnI 62.4 ± 1.6 57.8 ± 3.4 1.019 ± 0.034 -0.43 
formate dehydrogenase-N, 
cytochrome B556 (gamma)subunit, 
nitrate-inducible  
 greA 172.5 ± 12.4 90.0 ± 1.2 0.581 ± 0.045 -0.38 transcript cleavage factor  
 hupB 287.5 ± 19.6 116.5 ± 4.0 0.450 ± 0.030 -0.33 
HU, DNA-binding transcriptional 
regulator, betasubunit  
 glpE 144.2 ± 2.0 142.0 ± 2.6 1.086 ± 0.035 -0.33 
thiosulfate:cyanide 
sulfurtransferase(rhodanese)  
 ogrK 95.8 ± 9.5 145.2 ± 3.3 1.699 ± 0.153 -0.33 positive regulator of P2 growth 
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(insertion of P2ogr gene into the 
chromosome)  
 rplD 20.9 ± 1.5 41.0 ± 1.6 2.191 ± 0.226 -0.33 50S ribosomal subunit protein L4  
 dmsB 116.2 ± 5.3 156.3 ± 5.1 1.486 ± 0.067 -0.28 
dimethyl sulfoxide reductase, 
anaerobic, subunitB  
 rpsP 241.7 ± 3.7 118.5 ± 0.3 0.540 ± 0.007 -0.19 30S ribosomal subunit protein S16  
 rplX 150.6 ± 3.2 83.7 ± 3.5 0.613 ± 0.031 -0.19 50S ribosomal subunit protein L24  
 tpiA 138.5 ± 11.4 87.1 ± 2.2 0.700 ± 0.047 -0.19 triosephosphate isomerase  
 gapA 39.5 ± 2.0 62.6 ± 1.6 1.757 ± 0.135 -0.19 
glyceraldehyde-3-phosphate 
dehydrogenase A  
 rpsT 174.7 ± 12.0 133.7 ± 4.5 0.849 ± 0.050 -0.14 30S ribosomal subunit protein S20  
 rpsJ 170.2 ± 37.2 142.3 ± 1.6 1.015 ± 0.219 -0.14 30S ribosomal subunit protein S10  
 rplT 120.5 ± 8.5 112.6 ± 3.7 1.039 ± 0.077 -0.14 50S ribosomal subunit protein L20  
 ahpC 57.0 ± 5.0 64.9 ± 1.7 1.267 ± 0.078 -0.14 
alkyl hydroperoxide reductase, C22 
subunit  
 rpsK 109.9 ± 9.2 139.0 ± 3.5 1.411 ± 0.113 -0.14 30S ribosomal subunit protein S11  
 tsf 200.4 ± 2.8 103.8 ± 2.1 0.570 ± 0.008 0.00 protein chain elongation factor EF-Ts  
 rplU 173.3 ± 12.4 92.5 ± 4.9 0.595 ± 0.056 0.00 50S ribosomal subunit protein L21  
 rpmI 158.7 ± 4.0 104.2 ± 1.4 0.725 ± 0.025 0.00 50S ribosomal subunit protein L35  
 yjgF 131.9 ± 5.3 98.1 ± 3.0 0.824 ± 0.057 0.00 conserved protein, UPF0131 family  
 ppiB 133.6 ± 4.5 114.6 ± 2.7 0.945 ± 0.011 0.00 
peptidyl-prolyl cis-trans isomerase B 
(rotamaseB)  
 yjbJ 134.6 ± 4.4 158.7 ± 1.1 1.300 ± 0.035 0.00 conserved protein, UPF0337 family  
 rpsI 27.5 ± 2.8 78.6 ± 6.0 3.198 ± 0.324 0.00 30S ribosomal subunit protein S9  
 rpsF 31.7 ± 1.6 97.1 ± 0.8 3.392 ± 0.183 0.00 30S ribosomal subunit protein S6  
 
Table S2: 56 ORF-yfp fusions used for Arg CRI validation 
Genes are arranged by increasing values of Arg CRI. SArg-rich and SArg-limited refer to respective 
protein synthesis rates (a.u. per sec per cell). Robustness refers to the ratio between the two 
protein synthesis rates after normalization by the corresponding value for the AGA variant of yfp 
(this AGA variant was also used as the yfp tag in these ORF-yfp fusions). ± refers to standard 
error of measurement.  
Gene SArg-rich SArg-limited Robustness  
log2 
Arg CRI 
Gene product 
leuS 100.5 ± 2.6 16.1 ± 1.7 0.107 ± 0.012 -10.05 leucyl-tRNA synthetase  
 phoR 16.4 ± 3.2  0.7 ± 0.6 0.027 ± 0.029 -8.52 
sensory histidine kinase in two-
componentregulatory system with 
PhoB  
 glnG 61.0 ± 3.4 10.8 ± 2.3 0.118 ± 0.022 -8.51 
fused DNA-binding response regulator 
intwo-component regulatory system 
with GlnL: responseregulator/sigma54 
interaction protein  
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 asnS 15.5 ± 1.8  2.6 ± 0.1 0.114 ± 0.014 -8.38 asparaginyl tRNA synthetase  
 guaA 91.5 ± 4.2 11.7 ± 3.7 0.083 ± 0.024 -8.25 
GMP synthetase (glutamine 
aminotransferase)  
 thiH 53.9 ± 1.1  4.4 ± 1.3 0.054 ± 0.015 -7.16 
tyrosine lyase, involved in thiamin-
thiazolemoiety synthesis  
 fruR 44.7 ± 1.5  5.3 ± 0.1 0.079 ± 0.004 -6.54 
DNA-binding transcriptional dual 
regulator  
 argG 10.0 ± 0.9  2.5 ± 1.1 0.175 ± 0.088 -6.49 argininosuccinate synthetase  
 gpsA 81.9 ± 3.9  9.1 ± 4.2 0.073 ± 0.032 -5.81 
glycerol-3-phosphate dehydrogenase 
(NAD+)  
 rpoA 60.9 ± 1.6 10.5 ± 2.1 0.114 ± 0.022 -5.36 RNA polymerase, alpha subunit  
 yiiD 31.2 ± 1.8  9.8 ± 2.9 0.218 ± 0.078 -5.05 predicted acetyltransferase  
 agaR 53.2 ± 1.8  2.6 ± 0.8 0.032 ± 0.010 -5.01 
DNA-binding transcriptional repressor 
of the agaregulon  
 rimK 17.9 ± 2.6  9.8 ± 1.5 0.393 ± 0.106 -4.94 
ribosomal protein S6 modification 
protein  
 rpoH 75.2 ± 2.8  9.3 ± 2.9 0.081 ± 0.023 -4.76 
RNA polymerase, sigma 32 (sigma H) 
factor  
 melR 43.7 ± 0.4 11.1 ± 2.3 0.170 ± 0.036 -4.46 
DNA-binding transcriptional dual 
regulator  
 tdcB 32.1 ± 2.0 10.2 ± 2.9 0.208 ± 0.051 -3.83 
catabolic threonine dehydratase, PLP-
dependent  
 serC 68.2 ± 2.3 28.9 ± 4.2 0.284 ± 0.043 -3.79 
3-
phosphoserine/phosphohydroxythreo
nineaminotransferase  
 rnc 65.7 ± 2.5 15.4 ± 2.6 0.157 ± 0.028 -3.74 RNase III  
 chbR 22.3 ± 1.2  6.2 ± 2.1 0.190 ± 0.064 -3.66 
rRepressor, chb operon forN,N'-
diacetylchitobiose utilization  
 rsuA 100.3 ± 5.9 12.8 ± 2.8 0.084 ± 0.015 -3.65 
16S rRNA U516 pseudouridine 
synthase  
 tauC 70.1 ± 3.2  7.4 ± 1.3 0.071 ± 0.016 -3.5 taurine transporter subunit  
 smpB 55.3 ± 1.3 17.5 ± 0.8 0.211 ± 0.010 -3.42 trans-translation protein  
 carA 28.2 ± 1.1 14.0 ± 0.8 0.331 ± 0.005 -3.4 
carbamoyl phosphate synthetase small 
subunit,glutamine amidotransferase  
 ubiC 70.6 ± 1.8  4.7 ± 1.9 0.044 ± 0.018 -3.39 chorismate--pyruvate lyase  
 pth 71.2 ± 2.4 20.0 ± 0.8 0.187 ± 0.001 -3.21 peptidyl-tRNA hydrolase  
 rpsF 26.6 ± 1.9 14.7 ± 2.3 0.366 ± 0.043 -3.06 30S ribosomal subunit protein S6  
 gapA 34.3 ± 0.9 12.1 ± 1.9 0.234 ± 0.030 -2.86 
glyceraldehyde-3-phosphate 
dehydrogenase A  
 yihL 43.2 ± 3.4  6.7 ± 1.1 0.105 ± 0.022 -2.85 
predicted DNA-binding transcriptional 
regulator  
 allR 36.0 ± 1.5 17.1 ± 0.8 0.318 ± 0.026 -2.82 
DNA-binding transcriptional repressor 
for all(allantoin) and gcl (glyoxylate) 
operons;glyoxylate-induced  
 yfcN 74.2 ± 4.8 38.9 ± 7.3 0.353 ± 0.068 -2.8 conserved protein  
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 fdnI 42.7 ± 1.8 17.8 ± 3.2 0.277 ± 0.042 -2.65 
formate dehydrogenase-N, 
cytochrome B556 (gamma)subunit, 
nitrate-inducible  
 ruvA 53.2 ± 4.1 26.7 ± 1.1 0.341 ± 0.040 -2.59 
component of RuvABC resolvasome, 
regulatorysubunit  
 adiY 47.5 ± 8.2  6.1 ± 0.9 0.086 ± 0.003 -2.55 DNA-binding transcriptional activator  
 holD 15.1 ± 3.6  2.9 ± 1.3 0.153 ± 0.066 -2.43 DNA polymerase III, psi subunit  
 dmsB 68.1 ± 2.2 54.7 ± 6.5 0.537 ± 0.067 -2.42 
dimethyl sulfoxide reductase, 
anaerobic, subunitB  
 bglJ 10.5 ± 1.3  6.6 ± 0.7 0.420 ± 0.010 -2.39 
DNA-binding transcriptional activator 
for silentbgl operon, requires the bglJ4 
allele to function; LuxRfamily  
 yfdT 71.4 ± 1.4 17.6 ± 0.7 0.164 ± 0.005 -2.32 
CPS-53 (KpLE1) prophage; predicted 
protein  
 argF 64.9 ± 2.8 35.7 ± 2.5 0.371 ± 0.044 -2.01 
ornithine carbamoyltransferase 2, 
chain F; CP4-6prophage  
 rplU 102.0 ± 7.4 20.5 ± 4.2 0.134 ± 0.029 -1.89 50S ribosomal subunit protein L21  
 luxS 90.3 ± 1.4 54.9 ± 2.4 0.406 ± 0.018 -1.77 S-ribosylhomocysteine lyase  
 coaD 70.9 ± 1.5 45.3 ± 3.4 0.426 ± 0.036 -1.75 
pantetheine-phosphate 
adenylyltransferase  
 glnB 199.0 ± 6.0 61.9 ± 7.2 0.207 ± 0.021 -1.75 
regulatory protein P-II for 
glutaminesynthetase  
 uidR 32.2 ± 1.7 35.7 ± 1.5 0.745 ± 0.064 -1.5 DNA-binding transcriptional repressor  
 relB 69.6 ± 4.3 29.8 ± 0.5 0.287 ± 0.016 -1.35 
Qin prophage; bifunctional antitoxin of 
theRelE-RelB toxin-antitoxin system/ 
transcriptionalrepressor  
 btuE 106.1 ± 1.4 52.7 ± 4.0 0.331 ± 0.021 -1.35 glutathione peroxidase  
 argR 37.3 ± 3.4 13.7 ± 4.4 0.235 ± 0.054 -1.19 
DNA-binding transcriptional dual 
regulator,L-arginine-binding  
 ogrK 53.3 ± 1.5 29.3 ± 0.9 0.367 ± 0.013 -1.14 
positive regulator of P2 growth 
(insertion of P2ogr gene into the 
chromosome)  
 hupB 127.5 ± 3.6 71.2 ± 1.0 0.373 ± 0.008 -1.13 
HU, DNA-binding transcriptional 
regulator, betasubunit  
 ppiB 95.0 ± 2.7 57.2 ± 10.5 0.401 ± 0.069 -1.13 
peptidyl-prolyl cis-trans isomerase B 
(rotamaseB)  
 yjgF 92.2 ± 4.7 74.4 ± 3.6 0.540 ± 0.032 -1.13 conserved protein, UPF0131 family  
 kefF 68.6 ± 2.5 69.7 ± 7.6 0.677 ± 0.058 -1.11 
flavoprotein subunit for the KefC 
potassiumefflux system  
 yjbJ 92.0 ± 5.1 96.6 ± 30.0 0.730 ± 0.272 -1.02 conserved protein, UPF0337 family  
 leuL 36.7 ± 1.4 31.8 ± 2.2 0.577 ± 0.023 -0.97 leu operon leader peptide  
 rimM 86.4 ± 1.7 89.9 ± 3.3 0.694 ± 0.029 -0.82 16S rRNA processing protein  
 ydjO  9.9 ± 0.9 20.7 ± 1.6 1.432 ± 0.219 -0.74 predicted protein  
 mdtJ 21.0 ± 0.4 26.4 ± 1.5 0.841 ± 0.060 -0.41 multidrug efflux system transporter  
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Table S3: 21 ORF-yfp fusions co-expressed with 
GAG
Leu2 tRNA. 
Genes are arranged by increasing values of Leu CRI as calculated for 
GAG
Leu2 tRNA co-
expression (see Supplmenetary methods). SLeu-rich and SLeu-limited refer to respective protein 
synthesis rates (a.u. per sec per cell) under 
GAG
Leu2 tRNA co-expression. Robustness refers to 
the ratio between the two protein synthesis rates after normalization by the corresponding value 
for the CTG variant of yfp (see Fig. 1D). ± refers to standard error of measurement. Refer to 
Table S1 for corresponding values without 
GAG
Leu2 tRNA co-expression. 
Gene SLeu-rich SLeu-limited Robustness  
log2 
Leu CRI 
Gene product 
ygiD  8.2 ± 0.6  3.8 ± 0.8 0.515 ± 0.103 -5.69 predicted dioxygenase, LigB family  
 chbR 26.5 ± 2.5  7.3 ± 1.5 0.299 ± 0.043 -5.68 
rRepressor, chb operon forN,N'-
diacetylchitobiose utilization  
 yfcN 92.7 ± 2.6 12.1 ± 2.9 0.142 ± 0.030 -5.47 conserved protein  
 mdtJ 12.7 ± 0.8  5.7 ± 1.7 0.513 ± 0.165 -4.46 multidrug efflux system transporter  
 ilvD 62.5 ± 1.5 23.6 ± 0.8 0.417 ± 0.022 -4.29 dihydroxyacid dehydratase  
 aspS 54.1 ± 2.0 18.5 ± 1.8 0.379 ± 0.046 -4.24 aspartyl-tRNA synthetase  
 lysS 106.3 ± 4.7 35.2 ± 0.8 0.367 ± 0.025 -4.22 lysine tRNA synthetase, constitutive  
 leuC 100.7 ± 0.5 19.0 ± 1.7 0.208 ± 0.019 -4.04 
3-isopropylmalate dehydratase large 
subunit  
 ygbF 69.4 ± 3.4  8.1 ± 0.4 0.129 ± 0.009 -3.99 
probable ssRNA endonuclease, CRISP-
associatedprotein  
 pspA 65.1 ± 1.2 25.9 ± 2.0 0.437 ± 0.025 -3.91 
regulatory protein for phage-shock-
proteinoperon  
 guaA 122.0 ± 2.8 51.1 ± 1.9 0.462 ± 0.018 -3.27 
GMP synthetase (glutamine 
aminotransferase)  
 btuE 137.7 ± 4.6 57.5 ± 3.9 0.462 ± 0.044 -3.23 glutathione peroxidase  
 purA 73.3 ± 1.8 34.8 ± 2.7 0.522 ± 0.035 -3.16 adenylosuccinate synthetase  
 ompR 116.4 ± 1.0 50.7 ± 3.2 0.479 ± 0.027 -2.86 
DNA-binding response regulator in 
two-componentregulatory system 
with EnvZ  
 phnM 68.2 ± 4.4 48.4 ± 1.4 0.786 ± 0.044 -2.72 
carbon-phosphorus lyase complex 
subunit  
 msrB 113.4 ± 3.1 37.9 ± 2.1 0.370 ± 0.028 -2.68 methionine sulfoxide reductase B  
 purH 71.4 ± 1.3  7.9 ± 2.0 0.120 ± 0.028 -2.61 
fused 
IMPcyclohydrolase/phosphoribosylami
noimidazolecarboxamideformyltransfe
rase  
 coaD 98.3 ± 7.4 46.7 ± 1.9 0.526 ± 0.018 -2.58 
pantetheine-phosphate 
adenylyltransferase  
 rimM 114.3 ± 5.9 51.3 ± 1.1 0.498 ± 0.030 -1.99 16S rRNA processing protein  
 relB 79.9 ± 3.0 66.6 ± 3.3 0.923 ± 0.077 -1.73 
Qin prophage; bifunctional antitoxin of 
theRelE-RelB toxin-antitoxin system/ 
transcriptionalrepressor  
 proC 78.1 ± 2.0 36.7 ± 4.4 0.519 ± 0.070 -1.72 pyrroline-5-carboxylate 
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reductase,NAD(P)-binding 
 
Table S4: 63 synonymous mutants of 13 different ORF-yfp fusions.  
SLeu-rich and SLeu-limited refer to respective protein synthesis rates (a.u. per sec per cell) of mutant 
ORFs. Robustness refers to the ratio between the two protein synthesis rates after normalization 
by the corresponding value for the CTG variant of yfp (see Fig. 1D). ± refers to standard error of 
measurement. Refer to Table S1 for corresponding values of wild-type ORFs. The DNA 
sequence of the mutant variants below is provided in the gene_sequences.fasta file. 
Gene SLeu-rich SLeu-limited Robustness  log2 Leu CRI 
btuE-yfp mutant 1 137.0 ± 5.3 50.1 ± 1.1 0.403 ± 0.007 -2.22 
btuE-yfp mutant 4 131.5 ± 3.5 20.5 ± 0.5 0.172 ± 0.009 -3.06 
btuE-yfp mutant 5 138.9 ± 1.8 34.1 ± 0.1 0.270 ± 0.003 -2.62 
btuE-yfp mutant 7 123.4 ± 4.9 48.2 ± 1.8 0.433 ± 0.032 -2.22 
btuE-yfp mutant 8 130.7 ± 5.2 28.8 ± 0.9 0.243 ± 0.015 -3.06 
btuE-yfp mutant 9 128.9 ± 0.9 40.0 ± 0.6 0.342 ± 0.003 -2.62 
chbR-yfp mutant 1 29.5 ± 1.7 17.7 ± 0.3 0.663 ± 0.028 -2.81 
chbR-yfp mutant 2 26.7 ± 2.2 15.1 ± 0.4 0.634 ± 0.072 -3.25 
chbR-yfp mutant 3 31.7 ± 0.9 11.3 ± 0.6 0.393 ± 0.029 -5.31 
chbR-yfp mutant 4 36.0 ± 2.5  9.0 ± 0.3 0.279 ± 0.027 -6.2 
chbR-yfp mutant 5 28.9 ± 2.4 10.7 ± 0.2 0.414 ± 0.033 -5.76 
chbR-yfp mutant 6 32.6 ± 2.7  5.7 ± 0.5 0.197 ± 0.021 -7.03 
chbR-yfp mutant 7 32.1 ± 1.2  7.7 ± 0.5 0.267 ± 0.023 -5.8 
chbR-yfp mutant 9 31.3 ± 0.9  7.9 ± 0.5 0.278 ± 0.026 -6.64 
coaD-yfp mutant 1 92.3 ± 1.3 39.1 ± 1.3 0.467 ± 0.021 -1.89 
coaD-yfp mutant 2 91.7 ± 4.1 55.5 ± 0.8 0.669 ± 0.034 -1.1 
coaD-yfp mutant 3 94.0 ± 2.4 47.7 ± 2.3 0.558 ± 0.014 -1.5 
leuA-yfp mutant 6 70.5 ± 2.1 11.3 ± 0.3 0.177 ± 0.010 -4.4 
leuA-yfp mutant 8 77.9 ± 2.2  6.6 ± 1.4 0.093 ± 0.020 -5.23 
leuA-yfp mutant 9 70.0 ± 2.1  8.4 ± 0.2 0.132 ± 0.007 -4.84 
leuB-yfp mutant 7 273.5 ± 8.7  6.1 ± 0.9 0.025 ± 0.003 -4.81 
leuB-yfp mutant 8 273.3 ± 10.6  9.6 ± 1.0 0.039 ± 0.005 -4.02 
leuB-yfp mutant 9 274.9 ± 8.1  8.4 ± 1.7 0.034 ± 0.007 -3.97 
leuC-yfp mutant 5 86.8 ± 0.6  8.5 ± 1.7 0.108 ± 0.021 -3.64 
leuC-yfp mutant 7 95.6 ± 1.9  5.1 ± 1.7 0.059 ± 0.019 -3.3 
leuC-yfp mutant 8 100.5 ± 1.7  4.3 ± 0.9 0.047 ± 0.009 -3.69 
leuC-yfp mutant 9 80.0 ± 4.9 14.3 ± 0.8 0.198 ± 0.013 -3.25 
leuD-yfp mutant 2 123.6 ± 0.9 18.3 ± 1.2 0.163 ± 0.011 -2.76 
leuD-yfp mutant 3 123.1 ± 3.7 39.5 ± 1.0 0.355 ± 0.020 -1.48 
leuD-yfp mutant 4 122.0 ± 1.0 32.9 ± 0.3 0.297 ± 0.002 -1.92 
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mdtJ-yfp mutant 1 17.3 ± 0.6  9.1 ± 0.4 0.580 ± 0.020 -4.15 
mdtJ-yfp mutant 2 12.2 ± 0.5  5.8 ± 0.3 0.520 ± 0.008 -3.31 
mdtJ-yfp mutant 4 10.0 ± 0.9  4.3 ± 0.1 0.475 ± 0.047 -4.54 
mdtJ-yfp mutant 5 13.6 ± 2.1 11.4 ± 0.5 0.979 ± 0.190 -4.15 
mdtJ-yfp mutant 6  6.4 ± 0.9  5.1 ± 0.1 0.903 ± 0.125 -3.75 
mdtJ-yfp mutant 7  5.9 ± 3.1  4.3 ± 0.3 1.251 ± 0.488 -4.15 
mdtJ-yfp mutant 8 10.2 ± 1.5  8.3 ± 0.1 0.932 ± 0.117 -4.19 
mdtJ-yfp mutant 9 10.3 ± 0.8  9.6 ± 0.2 1.049 ± 0.087 -3.36 
msrB-yfp mutant 1 76.6 ± 1.9 23.7 ± 0.8 0.342 ± 0.014 -2.48 
msrB-yfp mutant 2 65.3 ± 1.6 20.7 ± 0.8 0.348 ± 0.005 -2.92 
msrB-yfp mutant 3 99.1 ± 2.7 27.8 ± 2.5 0.310 ± 0.031 -2.52 
msrB-yfp mutant 4 94.0 ± 1.5 36.2 ± 0.4 0.424 ± 0.005 -2.08 
pspA-yfp mutant 1 68.2 ± 1.9 16.3 ± 0.6 0.264 ± 0.006 -2.81 
pspA-yfp mutant 2 64.2 ± 0.5 15.0 ± 0.7 0.257 ± 0.011 -2.85 
pspA-yfp mutant 3 62.3 ± 1.5 28.5 ± 0.6 0.505 ± 0.016 -1.97 
pspA-yfp mutant 5 73.3 ± 1.3 14.0 ± 0.9 0.211 ± 0.018 -3.2 
pspA-yfp mutant 6 70.1 ± 3.0 18.3 ± 0.9 0.288 ± 0.013 -2.76 
pspA-yfp mutant 7 73.5 ± 1.4  8.5 ± 0.2 0.127 ± 0.002 -3.64 
pspA-yfp mutant 8 73.0 ± 1.2 12.3 ± 0.8 0.185 ± 0.012 -3.25 
yfcN-yfp mutant 1 103.0 ± 3.5  8.3 ± 1.3 0.088 ± 0.012 -4.82 
yfcN-yfp mutant 5 86.0 ± 3.6 14.9 ± 1.7 0.192 ± 0.022 -3.1 
yfcN-yfp mutant 6 90.5 ± 1.6  5.6 ± 0.7 0.069 ± 0.009 -5.31 
yfcN-yfp mutant 8 91.5 ± 4.1 14.1 ± 1.7 0.170 ± 0.017 -2.71 
yfcN-yfp mutant 9 85.5 ± 1.1  5.2 ± 0.4 0.067 ± 0.005 -4.87 
ygbF-yfp mutant 2 80.6 ± 2.6  6.2 ± 0.3 0.085 ± 0.006 -3.28 
ygbF-yfp mutant 3 68.5 ± 3.9 25.4 ± 1.4 0.413 ± 0.044 -1.65 
ygbF-yfp mutant 5 79.0 ± 4.1 25.1 ± 0.2 0.352 ± 0.017 -2.1 
ygbF-yfp mutant 6 65.3 ± 2.9 10.8 ± 0.6 0.183 ± 0.019 -2.44 
ygbF-yfp mutant 7 80.5 ± 4.0  8.3 ± 0.2 0.113 ± 0.004 -3.33 
ygbF-yfp mutant 8 70.4 ± 3.1 10.8 ± 0.9 0.170 ± 0.019 -2.89 
ygiD-yfp mutant 1 11.0 ± 1.0  2.1 ± 0.2 0.216 ± 0.009 -5.17 
ygiD-yfp mutant 3 11.3 ± 0.9  4.2 ± 0.3 0.417 ± 0.056 -4.73 
ygiD-yfp mutant 4 10.6 ± 0.5  5.4 ± 0.6 0.572 ± 0.090 -4.34 
ygiD-yfp mutant 5  7.2 ± 1.1  3.3 ± 0.5 0.514 ± 0.041 -5.17 
ygiD-yfp mutant 6  6.8 ± 1.2  2.7 ± 0.6 0.476 ± 0.131 -4.29 
ygiD-yfp mutant 7 12.3 ± 2.5  2.7 ± 0.4 0.251 ± 0.016 -6.06 
 
Table S5: List of strains used in this study 
Limiting AA Strain 
designation 
CGSC number Genotype 
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Leu, Arg CP78 4695 W3110, argH- leuB- thr- his- thi- 
Ser JW2880-1 10234 BW25113, ΔserA 
Pro JW0233-2 8468 BW25113, ΔproA 
Ile JW3745-2 10733 BW25113, ΔilvA 
Gln JW3841-1 10775 BW25113, ΔglnA 
Phe JW2580-1 10048 BW25113, ΔpheA 
- MG1655 6300 wild-type strain with known 
genome sequence 
 
Table S6: Initial concentrations of amino acids and methyl-esters used for amino acid 
limitation experiments 
 
Amino 
Acid 
Amino acid 
concentration 
in overnight 
cultures (µM) 
Amino acid 
concentration for 
amino acid limitation 
experiments (µM) 
Amino acid methyl-
ester concentration 
for amino acid 
limitation 
experiments (µM) 
Catalog number for 
amino acid methyl-
ester 
Leu 800 100 160 L1002 (Sigma) 
Arg 800 150 160 11030 (Sigma) 
Ser 10000 5000 800 412201 (Sigma) 
Pro 800 0 160 287067 (Sigma) 
Ile 800 100 160 I0522 (VWR) 
Gln 800 400 400 68604 (Astatech) 
Phe 800 50 50 P17202 (Sigma) 
 
Table S7: wi values for Leu codons under 
GAG
Leu2 co-expression 
Codon - log wi (with 
GAG
Leu2 co-expression) 
CTA 0.48 
CTC 0.05 
CTG 0.04 
CTT 0.02 
TTA 0.26 
TTG 0.33 
 
Table S8: qPCR primer sequences 
Gene Forward primer Reverse Primer 
yfp TCATGCTGTTTCATGTGATC AGGGTGATGCTACTTATGGC 
gapA GCTGAAGGCGAAATGAAAGG GTACCAGGATACCAGTTTCACG 
rpoD TGAAGCGAACTTACGTCTGG AGAACTTGTAACCACGGCG 
rpoS TCTCAACATACGCAACCTGG AGCTTATGGGACAACTCACG 
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rpoH TCGTAATTATGCGGGCTATGG CAGTGAACGGCGAAGGAG 
rpoE CCAGAAGGGAGATCAGAAAGC TACCACATCGGGAACATCAC 
rpoN TGATCCAACTCTCCCAATTCG TCGTGATTGGCTAACAGATCG 
fecI ACTACCACAGCTTCCTTAACG TTTCGCTGACCATTACCCG 
fliA CGCTATGCTGGATGAACTTCG CTAAACGTTCCGCTACCTCAG 
leuA GTCGCTAACTACAACGGTCG GCACGCCAGATATTGTTCAG 
ilvM GTTTCCACGTCTGCTCAATG CTGACTAAACAGTAAGTCGACCG 
ilvB TGAGTTTCCGTGTCCAATCC ATCTGATGCTGACCAACGTC 
 
Table S9: Codon- tRNA assignments 
tRNA 
unmodified 
anticodon 
modified anticodon (if known) 
cognate codons reference 
Leu1 CAG - CUG (1) 
Leu2 GAG - CUC, CUU (1) 
Leu3 UAG 
cmo
5
UAG CUA, CUG, 
CUU 
(1, 25) 
Leu4 CAA CmAA UUA, UUG (1, 26) 
Leu5 UAA cmnm
5
UmAA UUA, UUG (1, 26) 
Arg2 ACG 
ICG CGU, CGC, 
CGA 
(1, 26) 
Arg3 CCG - CGG (1) 
Arg4 UCU mnm
5
UCU AGA, AGG (1, 26) 
Arg5 CCU - AGG (1, 27) 
Ser1 UGA 
cmo
5
UGA UCA, UCU, 
UCG 
(1, 26) 
Ser2 CGA - UCG (1) 
Ser3 GCU - AGC, AGU (1) 
Ser5 GGA - UCC, UCU (1) 
Pro1 CGG - CCG (1) 
Pro2 GGG - CCC, CCU (1) 
65 
 
Pro3 UGG 
cmo
5
UGG CCA, CCU, 
CCG 
(1, 26) 
Ile1 GAU - AUC, AUU (1) 
Ile2 CAU k
2
CAU AUA (1, 26) 
Gln1 UUG mnm
5
s
2
UUG CAA, CAG (1, 26) 
Gln2 CUG - CAG (1) 
Phe GAA - UUC, UUU (1) 
 
